<SEC-DOCUMENT>0001628280-23-030392.txt : 20230823
<SEC-HEADER>0001628280-23-030392.hdr.sgml : 20230823
<ACCEPTANCE-DATETIME>20230823163311
ACCESSION NUMBER:		0001628280-23-030392
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20230818
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230823
DATE AS OF CHANGE:		20230823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JanOne Inc.
		CENTRAL INDEX KEY:			0000862861
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-HOME FURNITURE, FURNISHINGS & EQUIPMENT STORES [5700]
		IRS NUMBER:				411454591
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19621
		FILM NUMBER:		231197996

	BUSINESS ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119
		BUSINESS PHONE:		702-997-5968

	MAIL ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	APPLIANCE RECYCLING CENTERS OF AMERICA INC /MN
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>jan-20230818.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:58bc4d69-38a0-43b6-b1d7-be31e4cd6e81,g:f85bda19-a3ae-4927-bc65-6331e24f9e17,d:f5a0845e0f8c4eeab65c1ea5e80bb3ee--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>jan-20230818</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0000862861</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="jan-20230818.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-18</xbrli:startDate><xbrli:endDate>2023-08-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:6pt;padding-right:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 18, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">JANONE INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-19621</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">41-1454591</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">325 E. Warm Springs Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 102</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Las Vegas</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">NV</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">89119</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices and Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">702</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">997-5968</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">JAN</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The NASDAQ Stock Market LLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(The NASDAQ Capital Market)</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Section 1 &#8211; Registrant&#8217;s Business and Operations</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1.01 Entry into a Material Definitive Agreement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 18, 2023, JanOne Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) entered into a Securities Purchase Agreement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) with a certain institutional investor (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Investor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) for the sale by the Company in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) of: (i) 418,000 shares (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), at an offering price of $0.8811 per share and (ii) pre-funded warrants exercisable for up to 481,348 shares of Common Stock (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) to the Investor at an offering price equal to $0.8801 (equal to the purchase price per share of Common Stock sold in this Offering, minus $0.001) per Pre-Funded Warrant. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Pre-Funded Warrants were sold, in lieu of shares of Common Stock, to the Investor because its purchase of shares of Common Stock in the Offering would otherwise result in the Investor, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company&#8217;s outstanding Common Stock immediately following the consummation of the Offering. Each Pre-Funded Warrant represents the right to purchase one share of Common Stock at an exercise price of $0.001 per share. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until the Pre-Funded Warrants are exercised in full.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate gross proceeds from the Offering were approximately $790,000, before deducting the placement agent fees and related expenses. The Company intends to use the net proceeds for working capital and general corporate purposes. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Purchase Agreement contains customary representations, warranties and agreements by the Company and the Investor and customary indemnification rights and obligations of the parties. Pursuant to the terms of the Purchase Agreement, the Company has agreed to certain restrictions on the issuance and sale of its shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement) during the 15-day period following the closing of the Offering and certain restrictions on issuing any shares of Common Stock or Common Stock Equivalents in a Variable Rate Transaction (as defined in the Purchase Agreement) for twelve (12) months following the closing of the Offering.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In a concurrent private placement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Private Placement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), the Company also issued to the Investor warrants to purchase up to 899,348 shares of Common Stock (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). Each Warrant will be exercisable immediately following issuance at an exercise price of $0.7561 per share and will have a term equal to five years from the closing of the Private Placement. The Warrants and the shares of Common Stock issuable upon the exercise of the Warrants (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Warrant Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) are not being registered under the Securities Act of 1933, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). The Warrants are being offered pursuant to the exemption provided in Section 4(a)(2) of the Securities Act and Rule 506(b) promulgated thereunder. The Warrants are not and will not be listed for trading on any national securities exchange. The Investor is an &#8220;accredited investor&#8221; as such term is defined in Rule 501(a) under the Securities Act.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The closing of the Offering and the concurrent Private Placement occurred on August 22, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">H.C. Wainwright &amp; Co., LLC acted as the sole placement agent (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Placement Agent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) for the Company on a &#8220;reasonable best efforts&#8221; basis in connection with the Offering and the Private Placement. In connection with the closing of the Offering, the Placement Agent received an aggregate cash fee of approximately 7% of the gross proceeds raised in the Offering, a management fee of approximately 1% of the gross proceeds raised in the Offering, and reimbursement for accountable expenses incurred by it in connection with the Offering of $30,000. In addition, the Company granted warrants (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Placement Agent Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) to the Placement Agent, or its designees, to purchase up to an aggregate of 62,954 shares of the Company&#8217;s Common Stock. The Placement Agent Warrants have a per-share exercise price of $1.1014, are exercisable immediately, and have a term of exercise equal to five years from the commencement of sales in this Offering. Neither the Placement Agent Warrants nor the shares of Common Stock issuable upon the exercise of the Placement Agent Warrants (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Placement Agent Warrant Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) are registered under the Securities Act. The Placement Agent Warrants and the Placement Agent Warrant Shares were issued in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The shares of Common Stock and Pre-Funded Warrants sold in the Offering were offered and sold by the Company pursuant to an effective shelf registration statement on Form S&#8211;3 (File No. 333-251645), which was initially filed with the Securities and Exchange Commission on December 23, 2020, and was declared effective on December 29, 2020. On August 22, 2023, the Company filed a prospectus supplement with the SEC in connection with the sale of the Common Stock and the Pre-Funded Warrants.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The representations, warranties, and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement. In addition, such representations, warranties, and covenants (i) are intended as a way of allocating the risk between the parties to the Purchase Agreement and not as statements of fact and (ii) may apply standards of materiality in a way that is different from what may be viewed as material by stockholders of, or other investors in, the Company. Accordingly, the Purchase Agreement is included with this filing only to provide investors with information regarding the terms of the transaction, and not to provide investors with any other factual information regarding the Company. Stockholders should not rely on the representations, warranties, and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company or any of its subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in public disclosures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing descriptions of the Pre-Funded Warrants, the Warrants, the form of Placement Agent Warrant, and the Purchase Agreement are not complete and are qualified in their entirety by reference to the full text of such documents, copies of which are filed herewith as Exhibits 4.3, 4.4, 4.5, and 10.99 to this Current Report on Form 8-K and are incorporated by reference herein.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Current Report on Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">A copy of the opinion of Clark Hill LLP relating to the legality of the issuance and sale of the Shares is attached as Exhibit 5.1 hereto.</span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_62"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Section 3 &#8211; Securities and Trading Markets</span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_71"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3.02 Unregistered Sales of Equity Securities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The information set forth in Item 1.01 above related to the Warrants, the Warrant Shares, the Placement Agent Warrants, and the Placement Agent Warrant Shares is incorporated herein by reference into this Item 3.02.</span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_77"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Section 8 &#8211; Other Events</span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_83"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.01 Other Events.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On August 18, 2023, the Company issued a press release announcing the pricing of the Offering. On August 22, 2023, the Company issued a press release announcing the closing of the Offering. A copy of each of the press releases is furnished hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and neither shall be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8221;) or otherwise subject to the liabilities of that section, nor shall either be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_90"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Section 9 &#8211; Financial Statements and Exhibits</span></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_97"></div><div style="-sec-extract:summary;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="text-indent:34.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(d) Exhibits.</span></div><div style="text-indent:34.55pt"><span><br/></span></div><div style="text-indent:34.55pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex43janprefundedwarrantfin.htm">Form of Pre-Funded Warrant, dated August 22, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex44jancommonwarrantfinal.htm">Form of Warrant, dated August 22, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex45janplacementagentwarra.htm">Form of Placement Agent Warrant, dated August 22, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex51janoneopinionforwainwr.htm">Opinion of Clark Hill LLP.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1099janspafinal2.htm">Form of Securities Purchase Agreement, dated August 18, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Clark Hill LLP (included in Exhibit 5.1).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991janpricingpressreleas.htm">Press release dated August 18, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex992janclosingpressrelease.htm">Press release dated August 22, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if5a0845e0f8c4eeab65c1ea5e80bb3ee_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">JanOne Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">/s/ Tony Isaac</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tony Isaac</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dated:August 23, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>ex43janprefundedwarrantfin.htm
<DESCRIPTION>EX-4.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6be34e2b3b1341bd96fcf747bf2620cc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.3</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PRE-FUNDED COMMON STOCK PURCHASE WARRANT</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> JANONE INC.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Warrant Shares&#58; ______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial Exercise Date&#58; August ____, 2023</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) until this Warrant is exercised in full (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) but not thereafter, to subscribe for and purchase from JanOne Inc., a Nevada corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), up to ______ shares (as subject to adjustment hereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated August 18, 2023, among the Company and the purchasers signatory thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Exercise of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.  The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Holder and any assignee, by acceptance of this Warrant, acknowledge and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant.  The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing &#91;(A-B) (X)&#93; by (A), where&#58;</font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) &#61; as applicable&#58; (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bloomberg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) &#61; the Exercise Price of this Warrant, as adjusted hereunder&#59; and </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(X) &#61; the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bid Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">VWAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if the OTCQB Venture Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OTCQB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or the OTCQX Best Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OTCQX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pink Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.01pt;text-decoration:underline">Mechanics of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit and Withdrawal at Custodian service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DWAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Share Delivery Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).   Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.  If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Standard Settlement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.  Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12&#58;00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4&#58;00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt;text-decoration:underline">Delivery of New Warrants Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.01pt;text-decoration:underline">Rescission Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt;text-decoration:underline">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Buy-In</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and&#47;or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Fractional Shares or Scrip</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt;text-decoration:underline">Charges, Taxes and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.34pt;text-decoration:underline">Closing of Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.69pt;text-decoration:underline">Holder&#8217;s Exercise Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.    The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attribution Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.   In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be &#91;4.99%&#93; &#91;9.99%&#93; of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Stock Dividends and Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Company, at any time while this Warrant is outstanding&#58; (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt">&#91;RESERVED&#93;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Subsequent Rights Offerings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Pro Rata Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and&#47;or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Calculations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1&#47;100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Notice to Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Adjustment to Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt;text-decoration:underline">Notice to Allow Exercise by Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange&#59; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.  The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">New Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">No Rights as Stockholder Until Exercise&#59; No Settlement in Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Authorized Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Nonwaiver and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.  Without limiting any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.68pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">********************</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.820%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;__________________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Name&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Title&#58;</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div></div></div><div id="i6be34e2b3b1341bd96fcf747bf2620cc_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOTICE OF EXERCISE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;JANONE INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Payment shall take the form of (check applicable box)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;  &#93; in lawful money of the United States&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91; &#93; the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Warrant Shares shall be delivered to the following DWAC Account Number&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE OF HOLDER&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Investing Entity&#58; ________________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature of Authorized Signatory of Investing Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; _________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Authorized Signatory&#58; ___________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title of Authorized Signatory&#58; ____________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; ________________________________________________________________________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASSIGNMENT FORM</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> (To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.324%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Please Print)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Phone Number&#58;</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email Address&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(Please Print)</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58; _______________ __, ______</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Signature&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>ex44jancommonwarrantfinal.htm
<DESCRIPTION>EX-4.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic3b2ec31217e49f0a872bcca7682473f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.4</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A-2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMMON STOCK PURCHASE WARRANT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Warrant Shares&#58; _______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial Exercise Date&#58; August ___, 2023</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issue Date&#58; August ___, 2023</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS COMMON STOCK PURCHASE WARRANT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and on or prior to 5&#58;00 p.m. (New York City time) on August ___, 2028</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) but not thereafter, to subscribe for and purchase from JanOne Inc., a Nevada corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), up to ______ shares (as subject to adjustment hereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Common Stock.  The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated August 18, 2023, among the Company and the purchasers signatory thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Exercise of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Insert the date that is the five (5) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.  The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The exercise price per share of Common Stock under this Warrant shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">$0.7561</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, subject to adjustment hereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing &#91;(A-B) (X)&#93; by (A), where&#58;</font></div><div style="padding-left:99pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) &#61; as applicable&#58; (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bloomberg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) &#61; the Exercise Price of this Warrant, as adjusted hereunder&#59; and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(X) &#61; the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bid Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">VWAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if the OTCQB Venture Market (&#8220;OTCQB&#8221;) or the OTCQX Best Market (&#8220;OTCQX&#8221;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&#8220;Pink Market&#8221;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.01pt;text-decoration:underline">Mechanics of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.67pt;text-decoration:underline">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or its designee&#8217;s balance account with The Depository Trust Company through its Deposit and Withdrawal at Custodian service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DWAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Share Delivery Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).   Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided  that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.  If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Standard Settlement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.84pt;text-decoration:underline">Delivery of New Warrants Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.01pt;text-decoration:underline">Rescission Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.67pt;text-decoration:underline">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Buy-In</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and&#47;or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt;text-decoration:underline">No Fractional Shares or Scrip</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.67pt;text-decoration:underline">Charges, Taxes and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.34pt;text-decoration:underline">Closing of Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holder&#8217;s Exercise Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attribution Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.   In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be &#91;4.99%&#93; &#91;9.99%&#93; of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Stock Dividends and Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Company, at any time while this Warrant is outstanding&#58; (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Subsequent Rights Offerings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Pro Rata Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Black Scholes Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)   highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&#8217;s election and (ii) the date of consummation of the Fundamental Transaction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and&#47;or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Calculations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1&#47;100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Notice to Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Adjustment to Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt;text-decoration:underline">Notice to Allow Exercise by Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange&#59; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">New Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Representation by the Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">No Rights as Stockholder Until Exercise&#59; No Settlement in Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting any rights of a Holder to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Authorized Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Nonwaiver and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.  Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.68pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">********************</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.820%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;__________________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Name&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Title&#58;</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div></div></div><div id="ic3b2ec31217e49f0a872bcca7682473f_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOTICE OF EXERCISE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;JANONE INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Payment shall take the form of (check applicable box)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;  &#93; in lawful money of the United States&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91; &#93; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Warrant Shares shall be delivered to the following DWAC Account Number&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accredited Investor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE OF HOLDER&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Investing Entity&#58; ________________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature of Authorized Signatory of Investing Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; _________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Authorized Signatory&#58; ___________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title of Authorized Signatory&#58; ____________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; ________________________________________________________________________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASSIGNMENT FORM</font></div><div style="margin-bottom:6pt;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> (To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)</font></div><div style="margin-bottom:6pt;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.324%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Please Print)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Phone Number&#58;</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email Address&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(Please Print)</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58; _______________ __, ______</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Signature&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>4
<FILENAME>ex45janplacementagentwarra.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3a60025061ca4e8989c4c3a9da40c05e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.5</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Warrant Shares&#58; &#91;&#9679;&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial Exercise Date&#58; August 22, 2023</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) certifies that, for value received, &#91;&#9679;&#93;or its assigns (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and on or prior to 5&#58;00 p.m. (New York City time) on August 18, 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) but not thereafter, to subscribe for and purchase from JanOne Inc., a Nevada corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), up to &#91;&#9679;&#93; shares (as subject to adjustment hereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Common Stock.  The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement by and between the Company and H.C. Wainwright &#38; Co., LLC, dated as of March 22, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated August 18, 2023, among the Company and the purchasers signatory thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Exercise of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">specified in the applicable Notice of Exercise.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.  The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The exercise price per share of Common Stock under this Warrant shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">$1.1014</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, subject to adjustment hereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing &#91;(A-B) (X)&#93; by (A), where&#58;</font></div><div style="padding-left:99pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) &#61; as applicable&#58; (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bloomberg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) &#61; the Exercise Price of this Warrant, as adjusted hereunder&#59; and </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(X) &#61; the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div><div style="padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bid Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">VWAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if the OTCQB Venture Market (&#8220;OTCQB&#8221;) or the OTCQX Best Market (&#8220;OTCQX&#8221;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&#8220;Pink Market&#8221;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.01pt;text-decoration:underline">Mechanics of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.67pt;text-decoration:underline">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">through its Deposit and Withdrawal at Custodian service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DWAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Share Delivery Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).   Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided  that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.  If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Standard Settlement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.84pt;text-decoration:underline">Delivery of New Warrants Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.01pt;text-decoration:underline">Rescission Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.67pt;text-decoration:underline">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Buy-In</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and&#47;or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt;text-decoration:underline">No Fractional Shares or Scrip</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.67pt;text-decoration:underline">Charges, Taxes and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.34pt;text-decoration:underline">Closing of Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holder&#8217;s Exercise Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attribution Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.   In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Stock Dividends and Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Company, at any time while this Warrant is outstanding&#58; (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Subsequent Rights Offerings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Pro Rata Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise, other than cash (including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Black Scholes Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)   highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&#8217;s election and (ii) the date of consummation of the Fundamental Transaction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and&#47;or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Calculations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1&#47;100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Notice to Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Adjustment to Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt;text-decoration:underline">Notice to Allow Exercise by Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange&#59; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">New Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Representation by the Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">No Rights as Stockholder Until Exercise&#59; No Settlement in Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting any rights of a Holder to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Authorized Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt;text-decoration:underline">Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.02pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Nonwaiver and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.  Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered to the address of the holder in the Warrant Register.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.68pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.68pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">********************</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.820%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;__________________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Name&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Title&#58;</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div></div></div><div id="i3a60025061ca4e8989c4c3a9da40c05e_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOTICE OF EXERCISE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;JANONE INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Payment shall take the form of (check applicable box)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;  &#93; in lawful money of the United States&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91; &#93; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Warrant Shares shall be delivered to the following DWAC Account Number&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accredited Investor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE OF HOLDER&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Investing Entity&#58; ________________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature of Authorized Signatory of Investing Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; _________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Authorized Signatory&#58; ___________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title of Authorized Signatory&#58; ____________________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; ________________________________________________________________________________________</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASSIGNMENT FORM</font></div><div style="margin-bottom:6pt;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> (To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)</font></div><div style="margin-bottom:6pt;text-indent:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.324%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Please Print)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Phone Number&#58;</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email Address&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(Please Print)</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">______________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58; _______________ __, ______</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Signature&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holder&#8217;s Address&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ex51janoneopinionforwainwr.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i54006fbeab1a4a2090bdf545ff1ea57b_1"></div><div style="min-height:189.36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.661%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="6" style="padding:0 1pt"><div style="padding-right:3.1pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:132px"></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:36pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Clark Hill LLP</font></div><div style="padding-right:3.1pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">555 Flower Street, 24th Floor<br>Los Angeles, CA 90071</font></div><div style="padding-right:3.1pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T (213) 891-9100 </font></div><div style="padding-right:3.1pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">F (213) 488-1178</font></div></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">August 22, 2023 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities </font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the Securities Purchase Agreement<br>named therein and</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">H.C. Wainwright &#38; Co., LLC<br>430 Park Avenue<br>New York, New York 10022</font></div><div style="margin-bottom:12pt;padding-left:63.35pt;text-align:justify;text-indent:-27.35pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Re&#58;&#160;&#160;&#160;&#160;Securities Purchase Agreement, dated August 18, 2023&#59; Pre-Funded Common Stock Purchase Warrant and Common Stock Purchase Warrant, each dated August 22, 2023, all by and between JanOne Inc., a Nevada corporation (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and the Purchaser named therein (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchaser</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">We are rendering this letter as outside securities counsel to the Issuer in connection with the sale and issuance by the Issuer of&#58; (i)(a) an aggregate of 418,000 shares (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPA Stock</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of common stock, $0.001 par value per share (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), (b) an aggregate of 481,348 pre-funded warrants (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-funded Warrants</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), each for the purchase of one share of the Issuer&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-funded Warrant Shares</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in accordance with the terms and provisions of the Pre-Funded Common Stock Purchase Warrant (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-funded Warrant Agreement</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and (c) an aggregate of 899,348 unregistered Common Stock purchase warrants (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unregistered Warrants</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), each for the purchase of one share of the Issuer&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unregistered Warrant Shares</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in accordance with the terms and provisions of the Common Stock Purchase Warrant (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unregistered Warrant Agreement</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and (ii) an aggregate of 62,954 placement agent warrants (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Agent Warrants</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), each for the purchase of one share of the Issuer&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Agent Warrant Shares</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in accordance with the terms and provisions of the Placement Agent Common Stock Purchase Warrants (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Agent Warrant Agreements</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The shares of Common Stock and the Pre-funded Warrants and Unregistered Warrants were sold pursuant to the Securities Purchase Agreement, dated August 18, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPA</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between the Issuer and the Purchaser and the exercise of the Pre-Funded Warrants will be pursuant to the Pre-funded Common Stock Purchase Warrant, dated August 22, 2023.  The Placement Agent Warrants were issued pursuant to the Engagement Agreement, dated March 22, 2023, by and between the Issuer and H.C. Wainwright &#38; Co., LLC (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Wainwright Agreement</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The shares of Common Stock and the Pre-funded Warrants were sold pursuant to the Registration Statement on Form S-3, Registration No. 333-251645, filed by the Issuer with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and declared effective on December 29, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The prospectus included within the Registration Statement is hereinafter referred to as the &#8220;Base Prospectus.&#8221;  The prospectus supplement, dated August 18, 2023, in the form filed with the Commission under Rule 424(b) promulgated under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1933 Act</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.draft with private placement sections.2</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 2</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined herein are defined as set forth in the either or both of the SPA and the Pre-funded Warrant Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">In our capacity as special counsel, we have reviewed only the following documents and made no other investigation or inquiry&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.28pt">A copy of the executed SPA&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.54pt">A copy of the executed Pre-funded Warrant Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.8pt">A copy of the executed Unregistered Warrant Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.66pt">A copy of each of the executed Placement Agent Warrant Agreements&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.4pt">A copy of the Wainwright Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.66pt">A copy of the executed Secretary&#8217;s Certificate, dated as of even date herewith, made by Tony Isaac, an individual, solely in his capacity as the Secretary (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Secretary</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the Issuer (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Secretary&#8217;s Certificate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.92pt">A copy of the Articles of Incorporation of the Issuer, as amended or otherwise modified from time to time, as certified by the Secretary in the Secretary&#8217;s Certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.18pt">A copy of the Bylaws of the Issuer, as amended or otherwise modified from time to time, as certified by the Secretary in the Secretary&#8217;s Certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.78pt">A copy of the executed Written Consent of the Board of Directors of the Issuer, dated as of August 21, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consent</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as certified by the Secretary in the Secretary&#8217;s Certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.52pt">A copy of the Certificate of Existence of the Issuer, issued by the Secretary of State of the State of Nevada on August 21, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer Certificate of Existence</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), attached hereto as Exhibit &#8220;A-1&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.78pt">A copy of the certification of good standing of Soin Therapeutics LLC, issued by the Secretary of State of the State of Delaware on August 21, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Soin Delaware Certificate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), attached hereto as Exhibit &#8220;A-2&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.04pt">A copy of the executed Fact Certificate of the Issuer, attached hereto as Exhibit &#8220;B&#8221;&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.3pt">Copies of the Registration Statement, the Base Prospectus, and the Prospectus Supplement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Each of the documents listed in (i), (ii), and (iii) constitutes a &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Document</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;  The documents listed in (vii) and (viii) are each, a &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Constituent Document</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and collectively, are the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Constituent Documents</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;  For purposes of this letter, we have not reviewed any documents other </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 3</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">than the documents listed and&#47;or referenced in (i) through and including (xiii), above.  In particular, we have not conducted any independent investigation beyond our review of the documents listed and&#47;or referenced in (i) through and including (xiii), above, and we have not reviewed any document (other than the documents listed in and&#47;or referenced in (i) through and including (xiii), above) that is referred to or incorporated by reference into the documents reviewed by us.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">In making such examinations and rendering the opinions set forth below, we have made and relied upon, without independently investigating or verifying (and we make no representation as to the sufficiency of any inquiry or investigation we have made for the purposes of rendering the opinions set forth below), the following assumptions, which, to our knowledge, we have no reason to believe that any such assumption is untrue&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;each party to a Transaction Document (other than the Issuer) has satisfied those legal requirements that are applicable to it to the extent necessary to make the applicable Transaction Document enforceable against it&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;each party to a Transaction Document (other than the Issuer) has complied with all legal requirements pertaining to its status as such status relates to its rights to enforce the applicable Transaction Document against such party&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;each individual signer executing a Transaction Document (i) has the legal capacity to execute and deliver the applicable Transaction Document and (ii) in his&#47;her capacity as an officer or other representative has been duly elected and&#47;or appointed and is currently serving as such officer or other representative (other than the Issuer)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;each document submitted to us for review is accurate and complete, each such document that is an original is authentic, each such document that is a copy conforms to an authentic original, and all signatures on each such document are genuine&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;each public authority document that we have reviewed as specified herein is accurate, complete, and authentic and all official public records that we have reviewed as specified herein (including their proper filing) are accurate and complete&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;there has not been any mutual mistake of fact or misunderstanding, fraud, duress, or undue influence in connection with the execution, delivery and&#47;or performance of any Transaction Document&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;the conduct of each party to a Transaction Document is in compliance with any requirement of good faith, fair dealing, and conscionability&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;each of the parties to each applicable Transaction Document, their respective employees and agents have acted in good faith and without notice of (i) any defense against the enforcement of any rights created by, or adverse claim to, the applicable Transaction Document or (ii) any agreement, or court or administrative order, writ, judgment, or decree that would be violated by entering into the transactions contemplated by the applicable Transaction Document or by the execution, delivery, and&#47;or performance of the applicable Transaction Document (other than the Issuer)&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;there are no additional agreements or understandings among the parties, written or oral, and there is no usage of trade or course of prior dealing among the parties that would, in either case, define, supplement, or qualify the terms of each applicable Transaction Document&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;the constitutionality or validity of a relevant statute, rule, regulation, or agency action is not in issue, unless a reported decision in the State of New York or the State of Nevada has specifically addressed, but not resolved, or established, its unconstitutionality or invalidity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;the information contained in certificates of governmental officials is current through the date hereof notwithstanding any date contained therein&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(l)&#160;&#160;&#160;&#160;any remedies under each applicable Transaction Document will be exercised in a commercially reasonable manner.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The opinions herein are subject to the following limitations and qualifications&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;This letter is subject to the effect of bankruptcy, insolvency, reorganization, fraudulent transfer and conveyance, receivership, moratorium, and other similar laws affecting the rights and remedies of creditors generally.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;This letter is subject to the effect of general principles of equity, whether applied by a court of law or equity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;As to the accuracy of various factual matters material to the opinions expressed in this letter, in addition to the certificates and documents described above, we have relied upon the representations, warranties, and certifications of the parties to each applicable Transaction Document as contained in each applicable Transaction Document and the certifications of the Authorized Officer as contained in the Secretary&#8217;s Certificate and the Fact Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;As special counsel to the Issuer, we are only engaged to render substantive attention to the specific matters described in this letter and we express no opinion on any other matter on which we have not been engaged to render substantive legal advice by the Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;We express no opinion with respect to any matter involving financial information or relating to compliance with financial covenants or financial requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;To the extent the laws of the State of New York and&#47;or the State of Nevada apply any of the following rules to one or more of the provisions of a Transaction Document, the opinion expressed in paragraph 4 of this letter is subject to the effect of generally applicable rules of law that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;limit or affect the enforcement of provisions of a contract that purport to require waiver of the obligations of good faith, fair dealing, diligence, and reasonableness&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;limit the enforceability of provisions releasing, exculpating, or exempting a party from, or requiring indemnification of a party for, liability for its own action or inaction, to the extent the action or inaction involves gross negligence, recklessness, willful misconduct, or unlawful conduct&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 5</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;may, where less than all of a contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which the unenforceable portion is not an essential part of the agreed exchange&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;govern and afford judicial discretion regarding the determination of damages and entitlement to attorneys&#8217; fees and other costs&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;may, in the absence of a waiver or consent, discharge a guarantor to the extent that (1) action by a creditor impairs the value of collateral securing guaranteed debt to the detriment of the guarantor or (2) guaranteed debt is materially modified&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;may permit a party who has materially failed to render or offer performance required by the contract to cure that failure unless (1) permitting a cure would unreasonably hinder the aggrieved party from making substitute arrangements for performance or (2) it was important in the circumstances to the aggrieved party that performance occur by the date stated in the contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Whenever a statement in this letter is qualified by &#8220;to our knowledge&#8221;, it is intended to indicate that during the course of our representation of the Issuer no information that would give us actual knowledge of the inaccuracy of such statement has come to the attention of Randolf W. Katz, Esq. and Stephanie R. Hager, Esq., attorneys of this Firm who have rendered substantive legal services to the Issuer in connection with the execution and delivery by the Issuer of each Transaction Document and the transactions contemplated therein.  However, we have not undertaken any independent investigation or a search of our Firm&#8217;s files and records to determine the accuracy of such statements&#59; any limited inquiry undertaken by us during the preparation of this letter should not be regarded as such investigation&#59; and no inference as to our knowledge of any matters bearing on the accuracy of such statements should be drawn from the fact of our representation of the Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The law covered by this letter is limited to the federal laws of the United States of America, the laws of the State of New York and the laws of the State of Nevada (excluding the statutes and ordinances, the judicial and administrative decisions, and the rules and regulations of counties, towns, municipalities, and special political subdivisions or the effect thereof).  However, we express no opinion on the law that may be applied in any lawsuit or other legal action under either Transaction Document or the transactions contemplated thereby in any court of competent jurisdiction, including the application by such court of the choice of law rules of the jurisdiction in which such court is sitting.  We are not opining on specialized laws that are not customarily covered in opinion letters with respect to transactions of the kind contemplated by each Transaction Document, such as tax, insolvency, antitrust, foreign investment, fraudulent transfer and conveyance, pension, employee benefits, environmental, intellectual property, banking regulation, insurance, utilities, racketeering, criminal, civil forfeiture, anti-money laundering, anti-terrorism, labor, health and safety, and securities laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Based upon and subject to the foregoing, we are of the opinion that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;The Issuer is a corporation validly existing and in good standing under the laws of the State of Nevada.  The Issuer has all requisite power and authority, and all material governmental </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 6</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">licenses, authorizations, consents, and approvals that are required to own and operate its properties and assets and to carry on its business as now conducted and as proposed to be conducted (all as described in the Issuer&#8217;s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and subsequent SEC Reports).  The Issuer is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to qualify could have a Material Adverse Effect on the Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The following sole material subsidiary of the Issuer (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is a limited liability company, validly existing and in good standing under the laws of the State of Delaware&#58;  Soin Therapeutics LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The Issuer has all requisite power and authority (i) to execute, deliver, and perform each Transaction Document, (ii) to issue, sell, and deliver the shares of SPA Stock and the Pre-funded Warrants pursuant to the SPA, (iii) to issue, sell, and deliver the Pre-funded Warrant Shares, (iv) to issue, sell, and deliver the Unregistered Warrants, (v) to issue, sell, and deliver the Unregistered Warrant Shares, and (iv) to carry out and perform its obligations under, and to consummate the transactions contemplated by, each Transaction Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;All action on the part of the Issuer, its directors, and its stockholders necessary for (i)&#160;the authorization, execution, and delivery by the Issuer of each Transaction Document, (ii) the authorization, issuance, sale, and delivery of the shares of SPA Stock, the Pre-funded Warrants, and the Unregistered Warrants, (iii) upon exercise of the Pre-funded Warrants and the Unregistered Warrants, the authorization, issuance, sale, and delivery of the Pre-funded Warrant Shares and the Unregistered Warrant Shares, and (iv) the consummation by the Issuer of the transactions contemplated by the applicable Transaction Document has been duly taken.  Each Transaction Document has been duly and validly executed and delivered by the Issuer and constitutes the legal, valid, and binding obligation of the Issuer, enforceable against the Issuer in accordance with their respective terms, except that (a) such enforceability may be limited by bankruptcy, insolvency, or other similar laws affecting the enforcement of creditors&#8217; rights in general and (b) the remedies of specific performance and injunctive and other forms of injunctive relief may be subject to equitable defenses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;After giving effect to the transactions contemplated by the SPA, and immediately after the Closing, the authorized capital stock of the Issuer will consist of&#58;  an aggregate of (i) 200,000,000 shares of Common Stock, par value $0.001 per share, of which 3,768,878 shares are outstanding, (ii)&#160;700,000 shares of Common Stock are reserved for issuance pursuant to the Issuer&#8217;s stock option plans, (iii) 111,111 shares and 33,363 shares of Common Stock, respectively, are issuable and reserved for issuance pursuant to outstanding stock options and outstanding common stock purchase warrants exercisable for Common Stock, and (iv) 2,000,000 shares of the Issuer&#8217;s preferred stock, par value $0.001 per share, of which 209,706 shares of Series A-1 Convertible Preferred Stock and 100,000 shares of Series S Convertible Preferred Stock are issued and outstanding, respectively.  All presently issued and outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and nonassessable and free of any preemptive or similar rights, and have been issued in compliance with applicable securities laws and regulations.  The shares of SPA Stock, the Pre-funded Warrants, and the Unregistered Warrants that are being sold and issued on the date hereof pursuant to the SPA have been duly authorized and validly issued and are fully paid and nonassessable and free of preemptive or similar rights, and have been issued in </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 7</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">compliance with applicable securities laws, rules, and regulations.  To our knowledge, except for rights described hereinabove and except for the Pre-funded Warrants and the Unregistered Warrants, there are no other options, warrants, conversion privileges, or other rights presently outstanding to purchase or otherwise acquire from the Issuer any capital stock or other securities of the Issuer, or any other agreements to issue any such securities or rights.  The rights, privileges, and preferences of the Common Stock are as stated in in Exhibit 4.1 to the Issuer&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The Registration Statement filed with the Commission, No. 333-251645, which registers the sale of the shares of SPA Stock, the Pre-funded Warrants, and the Pre-funded Warrant Shares to the Purchaser, is currently effective.  The Registration Statement and the Prospectus and any post-effective amendments or supplements thereto (other than the financial statements included therein, as to which no opinion need be rendered) each as of their respective dates complied, and complies as of the date hereof, as to form in all material respects with the requirements of the Securities Act and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;To our knowledge, the Issuer has filed all reports (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC Reports</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) required to be filed by it under Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  As of their respective filing dates, the SEC Reports complied in all material respects as to form with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;The execution, delivery, and performance by the Issuer of, and the compliance by the Issuer with the terms of, each Transaction Document and the issuance, sale, and delivery of the shares of SPA Stock, the Pre-funded Warrants, and the Unregistered Warrants pursuant to the SPA do not (a) conflict with or result in a violation of any provision of law, rule, or regulation or any rule or regulation of any Trading Market applicable to the Issuer or its Subsidiary or of the Articles of Incorporation or bylaws or other similar organizational documents of the Issuer or its Subsidiary, (b) conflict with, result in a breach of, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or result in or permit the termination or modification of, any agreement, instrument, order, writ, judgment, or decree known to us to which the Issuer or its Subsidiary is a party or is subject, or (c) result in the creation or imposition of any lien, claim, or encumbrance on any of the assets or properties of the Issuer or its Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;To our knowledge, there is no claim, action, suit, proceeding, arbitration, investigation, or inquiry, pending or threatened, before any court or governmental or administrative body or agency, or any private arbitration tribunal, against the Issuer or its Subsidiary, or any of its officers, directors, or employees (in connection with the discharge of their respective duties as officers, directors, and employees), of the Issuer or its Subsidiary, or affecting any of its properties or assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;In connection with the valid execution, delivery, and performance by the Issuer of each Transaction Document, or the offer, sale, issuance, or delivery of the SPA Stock or the Pre-funded Warrants or the Unregistered Warrants or the consummation of the transactions contemplated by each applicable Transaction Document, no consent, license, permit, waiver, approval, or authorization of, or designation, declaration, registration, or filing with, any court, governmental, or regulatory authority, or self-regulatory organization, is required.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 8</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;The Issuer is not, and after the consummation of the transactions contemplated by each Transaction Document shall not be, an Investment Company within the meaning of the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;Assuming the due performance by the Issuer and the Purchaser of the covenants and agreements set forth in the SPA and the Unregistered Warrant Agreement and the validity of the representations and warranties of the Purchaser contained therein, and compliance with applicable federal and state securities laws and regulations in connection with the offer, sale, issuance, or delivery of the Unregistered Warrants, based on current interpretations by the Staff of the Securities and Exchange Commission it is not necessary in connection therewith to register the Unregistered Warrants or the Unregistered Warrant Shares under the 1933 Act, it being understood that no opinion is being expressed as to any resale of any of the Unregistered Warrant Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;No consent, approval, authorization, or other action by, and no notice to or filing with, any Federal governmental authority or regulatory body pursuant to any Federal statute that we, based on our experience, recognize as applicable to the Issuer in a transaction as contemplated by the SPA and the Unregistered Warrant Agreement in respect of the offer, sale, issuance, or delivery of the Unregistered Warrants and the Unregistered Warran Shares (other than filings and other actions required pursuant to Federal and state securities or blue sky laws) is required for the due execution, delivery, and consummation by the Issuer of its obligations under the SPA and the Unregistered Warrant Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">This letter deals only with the specific legal issues it explicitly addresses.  Accordingly, an express opinion concerning a particular legal issue does not address any other matter.  In addition, we express no opinion on any matter that is affected by any actual fact or circumstance inconsistent with or contrary to (a) any assumptions set forth in this letter or (b) the statements contained in any document referred to herein or therein as one on which we have relied, except for any such assumption, fact or circumstances known by us to be untrue.  The opinions set forth in this letter are based on the facts in existence and laws in effect on the date of this letter, and we have no obligation to advise you of changes of law or fact that occur after the date hereof, even though the change may affect the legal analysis, a legal conclusion, or an informational confirmation contained herein.  This letter is an opinion of counsel only and is not, nor may it be interpreted as or deemed to be, a warranty or guaranty of any Transaction Document and&#47;or the transactions contemplated therein, in each case as referenced herein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The opinions expressed in this letter are solely for the benefit of the Purchaser and the Placement Agent and the counter-party to the Transaction Documents in connection with each Transaction Document.  This letter is not to be used, circulated, quoted, or otherwise referred to other than in connection with the transactions contemplated by each Transaction Document and, except as set forth below, may not be relied on by you for any other purpose and it may not be relied on by any other person for any purpose&#59; provided that copies of this letter may be shown (i) to your independent auditors and attorneys, (ii) to regulatory agencies having supervisory authority over you, for purposes of confirming the existence of this letter, and (iii) in response to a court order or other applicable legal process.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">We bring to your attention that our legal opinion is an expression of professional judgment and not a guarantee of result.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:189.36pt;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">The Purchaser of Securities <br>Pursuant to the Securities Purchase Agreement<br>and named therein and<br>H.C. Wainwright &#38; Co., LLC<br>August 22, 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Page 9</font></div></div><div style="margin-bottom:36pt;padding-left:198pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="margin-bottom:36pt;padding-left:234pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:100%">Clark Hill LLP</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:100%">JanOne opinion for Wainwright closing August 2023.final</font><font style="color:#00cd7d;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;clarkhill.com</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.99
<SEQUENCE>6
<FILENAME>ex1099janspafinal2.htm
<DESCRIPTION>EX-10.99
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i26b7ca16728d40baab2dd5fc12274427_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:right;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 10.99</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECURITIES PURCHASE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Securities Purchase Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is dated as of August 18, 2023, between JanOne Inc., a Nevada corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchaser</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act (as defined below) as to the Shares and the Pre-Funded Warrants and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and&#47;or Regulation D thereunder as to the Common Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.7pt"><br>DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline"> Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acquiring Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 4.5.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the board of directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221;&#160; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Trading Day following the date hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the common stock of the Company, par value $0.001  per share, and any other class of securities into which such securities may hereafter be reclassified or changed. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Common Warrants shall be exercisable immediately and have a term of exercise equal to five (5) years, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the shares of Common Stock issuable upon exercise of the Common Warrants.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Clark Hill LLP, with offices located at 555 South Flower Street, 24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Floor, Los Angeles, California 90071. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9&#58;00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9&#58;01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9&#58;00 a.m. (New York City time) on any Trading Day, no later than 9&#58;01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Ellenoff Grossman &#38; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Evaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(s). </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exempt Issuance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities upon exercise of warrants to the Placement Agent and&#47;or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FCPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(hh).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FDCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(hh).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(aa).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(p).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legend Removal Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 4.1(c).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning assigned to such term in Section 3.1(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Per Share Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; equals $0.8811, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Prefunded Warrant shall be the Per Share Purchase Price minus $0.001.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pharmaceutical Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(hh). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means H.C. Wainwright &#38; Co., LLC.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prefunded Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prefunded Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the shares of Common Stock issuable upon exercise of the Prefunded Warrants.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the final prospectus filed for the Registration Statement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchaser Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 4.8.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the effective registration statement with Commission file No. 333-251645 which registers the sale of the Shares, the Prefunded Warrants and the Prefunded Warrant Shares to the Purchasers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 144</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 424</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Shares, the Warrants and the Warrant Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Short Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and&#47;or borrowing shares of Common Stock).&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subscription Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amount,&#8221; in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&#8217;s aggregate exercise price of the Prefunded Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a day on which the principal Trading Market is open for trading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question&#58; the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, and the New York Stock Exchange (or any successors to any of the foregoing).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Agreement, the Warrants, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means EQ By Equiniti, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120 and an email address of Daisy.Kuhn&#64;equiniti.com, and any successor transfer agent of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Variable Rate Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning ascribed to such term in Section 4.12(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">VWAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any date, the price determined by the first of the following clauses that applies&#58; (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9&#58;30 a.m. (New York City time) to 4&#58;02 p.m. (New York City time)), (b)&#160; if the OTCQB Venture Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OTCQB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or the OTCQX Best Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OTCQX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the Pink Open Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pink Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) operated by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Prefunded Warrants and the Common Warrants.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Warrant Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the shares of Common Stock issuable upon exercise of the Warrants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:2.04pt"><br>PURCHASE AND SALE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $792,416 of Shares and Common Warrants&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">howeve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">r, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&#8217;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#8217;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser may elect to purchase Prefunded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date.  Each Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &#8220;Delivery Versus Payment&#8221; settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares, a Prefunded Warrant (if applicable) and a Common Warrant as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing.  Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of EGS or shall take place remotely by electronic transfer of the Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &#8220;Delivery Versus Payment&#8221; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DVP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&#8217; names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser&#59; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).  Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-Settlement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), such Purchaser sells to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-Settlement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, such Pre-Settlement Shares at the Closing&#59; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&#8217;s receipt of the purchase price of such Pre-Settlement Shares hereunder&#59; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to effect any such sale, if any. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Prefunded Warrants) delivered on or prior to 12&#58;00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Prefunded Warrant Shares subject to such notice(s) by 4&#58;00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Prefunded Warrants) for purposes hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Deliveries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">this Agreement duly executed by the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">a legal opinion of Company Counsel directed to the Placement Agent and the Purchasers, in a form reasonably acceptable to the Placement Agent and Purchasers&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">subject to Section 2.1, the Company shall have provided each Purchaser with the Company&#8217;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">subject to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit and Withdrawal at Custodian service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DWAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) Shares equal to such Purchaser&#8217;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">a Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the sum of such Purchaser&#8217;s Shares and Prefunded Warrants on the date hereof, with an exercise price equal to $0.7561, subject to adjustment therein&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">for each Purchaser of Prefunded Warrants pursuant to Section 2.1, a Prefunded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&#8217;s Subscription Amount applicable to Prefunded Warrant divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject to adjustment therein&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">this Agreement duly executed by such Purchaser&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">such Purchaser&#8217;s Subscription Amount, which shall be made available for &#8220;Delivery Versus Payment&#8221; settlement with the Company or its designee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Closing Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) as of such date)&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date)&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">there shall have been no Material Adverse Effect with respect to the Company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.38pt"><br>REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby makes the following representations and warranties to each Purchaser&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports.  The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.  If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Organization and Qualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.  Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.  Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in&#58; (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Authorization&#59; Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.  The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.  This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected&#59; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Filings, Consents and Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than&#58; (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Issuance of the Securities&#59; Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.  The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.  The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on&#160;December 29, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement.  The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.  The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b).  At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading&#59; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set forth in General Instruction I.B.6 of Form S-3.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The capitalization of the Company as of the date hereof is as set forth in the SEC Reports.  The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and&#47;or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.  No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.  Except as a result of the purchase and sale of the Securities and as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary.  The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary.  There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.  No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.  There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">SEC Reports&#59; Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.  As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.  Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Material Changes&#59; Undisclosed Events, Liabilities or Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Since the date of the latest audited financial statements included within the SEC Reports, except as set forth in a subsequent SEC Report, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.  The Company does not have pending before the Commission any request for confidential treatment of information.  Except for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect.  Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.  There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.  The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Labor Relations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.  None of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.  To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters.  The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Company nor any Subsidiary&#58; (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses&#59; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Regulatory Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Title to Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.  Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.  Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect.  To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.  The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount.  Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Transactions With Affiliates and Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Sarbanes-Oxley&#59; Internal Accounting Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date.  The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that&#58; (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms.  The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Evaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.  Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.36pt;text-decoration:underline">Certain Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except for fees payable by the Company to the Placement Agent, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.  The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Investment Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.  The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Registration Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Other than as set forth in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Listing and Maintenance Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.  The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt;text-decoration:underline">Application of Takeover Protections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.   The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company.  All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading.  The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Integrated Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the Common Warrants or Common Warrant Shares under the Securities </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Act, or (ii) any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.  The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).  The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date.  The SEC Reports set forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.  For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business&#59; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.  Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.38pt;text-decoration:underline">Tax Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.  There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ab)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">Foreign Corrupt Practices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ac)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.38pt;text-decoration:underline">Accountants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company&#8217;s accounting firm is set forth in the SEC Reports.  To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for the fiscal year ending December 31, 2023.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ad)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment Regarding Purchasers&#8217; Purchase of Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.  The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217; purchase of the Securities.  The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ae)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.38pt;text-decoration:underline">Acknowledgment Regarding Purchaser&#8217;s Trading Activity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that&#58; (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and&#47;or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the Securities for any specified term&#59; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities&#59; (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction.  The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the Company at and after the time that the hedging activities are being conducted.&#160; The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(af)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.71pt;text-decoration:underline">Regulation M Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ag)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FDCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is manufactured, packaged, labeled, tested, distributed, sold, and&#47;or marketed by the Company or any of its Subsidiaries (each such product, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pharmaceutical Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and&#47;or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect.  There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect.  The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA.&#160; The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ah)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">Cybersecurity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; (i)(x) There has been no security breach or other compromise of or relating to any of the Company&#8217;s or any Subsidiary&#8217;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IT Systems and Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data&#59; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect&#59; (iii)&#160;the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">operation, redundancy and security of all IT Systems and Data&#59; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ai)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.37pt;text-decoration:underline">Stock Option Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been backdated.  The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(aj)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.37pt;text-decoration:underline">Office of Foreign Assets Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company  or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ak)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">U.S. Real Property Holding Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(al)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.37pt;text-decoration:underline">Bank Holding Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">BHCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.  Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(am)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.37pt;text-decoration:underline">Money Laundering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(an)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Common Warrants or the Common Warrant Shares by the Company to the Purchasers as contemplated hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ao)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">No General Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Common Warrants or the Common </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Warrant Shares by any form of general solicitation or general advertising.  The Company has offered the Common Warrants or the Common Warrant Shares for sale only to the Purchasers and certain other &#8220;accredited investors&#8221; within the meaning of Rule 501 under the Securities Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ap)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">No Disqualification Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  With respect to the Common Warrants or the Common Warrant Shares to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer Covered Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is subject to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualification Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(aq)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.7pt;text-decoration:underline">Other Covered Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ar)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.71pt;text-decoration:underline">Notice of Disqualification Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Representations and Warranties of the Purchasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date)&#58;</font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Organization&#59; Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.  Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except&#58; (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Understandings or Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).  Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.  Such Purchaser understands that the Common Warrants or the Common Warrant Shares are &#8220;restricted securities&#8221; and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).</font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:1.7pt;text-decoration:underline">Purchaser Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act.  </font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Experience of Such Purchaser</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment.  Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Access to Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities&#59; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment&#59; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.&#160; Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.&#160; Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it.&#160; In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Certain Transactions and Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">executed any purchases or sales, including Short Sales,&#160;of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.  Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.  Other than to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</font></div><div style="margin-bottom:12pt;padding-left:21pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">General Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and&#47;or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.  Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.04pt"><br>OTHER AGREEMENTS OF THE PARTIES</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Removal of Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.7pt">The Common Warrants or the Common Warrant Shares may only be disposed of in compliance with state and federal securities laws.  In connection with any transfer of Common Warrants or the Common Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Common Warrant under the Securities Act. </font></div><div style="margin-bottom:12pt;padding-left:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.02pt"> The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Common Warrants or the Common Warrant Shares in the following form&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Common Warrants or the Common Warrant Shares to a financial institution that is an &#8220;accredited investor&#8221; as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Common Warrants or the Common Warrant Shares to the pledgees or secured parties.  Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith.  Further, no notice shall be required of such pledge.  At the appropriate Purchaser&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Common Warrants or the Common Warrant Shares may reasonably request in connection with a pledge or transfer of the Common Warrants or the Common Warrant Shares.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Certificates evidencing the Common Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof)&#58; (i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such Common Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Common Warrants), or (iii) if such Common Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively.  If all or any portion of a Common Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Common Warrant Shares, or if such Common Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Common Warrants) or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Common Warrant Shares shall be issued free of all legends.  The Company agrees that following such time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Common Warrant Shares, as applicable, issued with a restrictive legend (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legend Removal Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), deliver or cause to be delivered to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Purchaser a certificate representing such shares that is free from all restrictive and other legends.  The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.  Common Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company System as directed by such Purchaser.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Standard Settlement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Common Warrant Shares issued with a restrictive legend.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of Common Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such Purchaser&#8217;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Buy-In Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) over the product of (A) such number of Common Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Common Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this Section 4.1(d).  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Shares and the Pre-Funded Warrants shall be issued free of legends.  If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Pre-Funded Warrant Shares or if the Pre-Funded Warrant is exercised via cashless exercise, the Pre-Funded Warrant Shares issued pursuant to any such exercise shall be issued free of all legends.  If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Pre-Funded Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Pre-Funded Warrant Shares, the Company shall immediately notify the holders of the Pre-Funded Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Pre-Funded Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Pre-Funded Warrant Shares in compliance with applicable federal and state securities laws).  The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Pre-Funded Warrant Shares effective during the term of the Pre-Funded Warrants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Furnishing of Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Common Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Common Warrant Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser&#8217;s Common Warrants on the day of a Public Information Failure and on every thirtieth (30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required&#160;for the Purchasers to transfer the Common Warrant Shares pursuant to Rule 144.&#160; The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Information Failure Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;&#160; Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payments are incurred and (ii) the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Business Day after the event or failure giving rise to the Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payments is cured.&#160; In the event the Company fails to make Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payments in a timely manner, such Public Information Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&#8217;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and&#47;or injunctive relief. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Common Warrants or Common Warrant Shares or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Securities Laws Disclosure&#59; Publicity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act.  From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, in connection with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">transactions contemplated by the Transaction Documents.  In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.  Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Stockholder Rights Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acquiring Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed in writing with the Company to keep such information confidential.  The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.  To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in the Prospectus Supplement, the Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and shall not use such proceeds&#58; (a) for the satisfaction of any portion of the Company&#8217;s debt (other than payment of trade payables in the ordinary course of the Company&#8217;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indemnification of Purchasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;Purchaser Party&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such  Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct.  If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.  Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.  The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed&#59; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations made by such Purchaser Party in this Agreement.  The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred.  The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Reservation of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Listing of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.  The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market.  The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">&#91;RESERVED&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Subsequent Equity Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">From the date hereof until fifteen (15) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing a registration statement on Form S-8 in connection with any employee benefit plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">From the date hereof until one (1) year following the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Variable Rate Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and&#47;or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &#8220;at-the-market offering&#8221;, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, after fifteen (15) days after the Closing Date, the entry into and&#47;or issuance of shares of Common Stock in an &#8220;at the market&#8221; offering with the Placement Agent as sales agent shall not be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">deemed a Variable Rate Transaction.   Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Equal Treatment of Purchasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.  For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Certain Transactions and Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4.&#160; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed to its legal and other representatives).&#160; Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section 4.4.&#160; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Capital Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares and Prefunded Warrants other than a reverse stock split that is required, in the good faith determination of the Board of Directors, to maintain the listing of the Common Stock on the Trading Market.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Exercise Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants.  No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants.  Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants.  The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Form D&#59; Blue Sky Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company agrees to timely file a Form D with respect to the Common Warrant and Common Warrant Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Common Warrant and Common Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or &#8220;Blue Sky&#8221; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:2.7pt"><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Trading Day following the date hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.  The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of&#58; (a) the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5&#58;30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5&#58;30 p.m. (New York City time) on any Trading Day, (c) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">given.  The address for such notices and communications shall be as set forth on the signature pages attached hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Amendments&#59; Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Prefunded Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required.  No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.  The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).  Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2.  This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.  Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">improper or is an inconvenient venue for such Proceeding.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.   If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart.  In the event that any signature is delivered by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such &#8220;.pdf&#8221; signature page were an original thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Rescission and Withdrawal Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Replacement of Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.  The applicant for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents.  The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Payment Set Aside</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Independent Nature of Purchasers&#8217; Obligations and Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document.  Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.  Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.  Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.  For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through EGS.  EGS does not represent any of the Purchasers and only represents the Placement Agent.  The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.  It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Liquidated Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Saturdays, Sundays, Holidays, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that each of them and&#47;or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:15pt;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(Signature Pages Follow)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JANONE INC.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Address for Notice&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;__________________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Name&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Title&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With a copy to (which shall not constitute notice)&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">E-Mail&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SIGNATURE PAGE FOR PURCHASER FOLLOWS&#93;</font></div><div style="padding-right:-18pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;PURCHASER SIGNATURE PAGES TO JAN SECURITIES PURCHASE AGREEMENT&#93;</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Name of Purchaser&#58; ________________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:232%">Signature of Authorized Signatory of Purchaser</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">&#58; _________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Name of Authorized Signatory&#58; _______________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Title of Authorized Signatory&#58; ________________________________________________</font></div><div style="padding-right:-36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Email Address of Authorized Signatory&#58;_________________________________________</font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address for Notice to Purchaser&#58;</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address for Delivery of Warrants to Purchaser (if not same as address for notice)&#58;</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subscription Amount&#58; $_________________</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares&#58; _________________</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prefunded Warrant Shares&#58; __________________ Beneficial Ownership Blocker </font><font style="font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 4.99% or </font><font style="font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 9.99%</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Common Warrant Shares&#58; __________________ Beneficial Ownership Blocker </font><font style="font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 4.99% or </font><font style="font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 9.99%</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="padding-right:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EIN Number&#58; _______________________</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="text-align:justify"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</font></div><div style="padding-right:-36pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGES CONTINUE&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex991janpricingpressreleas.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie57ba2bef1e841118287ec64bc572e7f_1"></div><div style="min-height:90.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-align:right;text-indent:-199.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-indent:-199.15pt"><font><br></font></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-indent:-199.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LAS VEGAS, August 18, 2023 &#47;PRNewswire&#47; -- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JanOne (Nasdaq&#58; JAN (the &#8220;Company&#8221;), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 899,348 shares of the Company&#8217;s common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.8811 per share of common stock (or prefunded warrant) in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase 899,348 shares of common stock at an exercise price of $0.7561 per share.  The warrants are exercisable immediately and have a term of exercise equal to five years.  The closing of the registered direct offering and the concurrent private placement is expected to occur on or about August 22, 2023, subject to the satisfaction of customary closing conditions.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.C. Wainwright &#38; Co. is acting as the exclusive placement agent for the offering.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">The gross proceeds to the Company from the offerings are expected to be approximately $790,000, before deducting the placement agent&#8217;s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offerings for working capital and general corporate purposes.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shares of common stock, prefunded warrants and shares of common stock underlying the prefunded warrants described above (but not the warrants issued in the concurrent private placement or the shares of common stock underlying the warrants) are being offered by the Company pursuant to a &#8220;shelf&#8221; registration statement on Form S-3 (File No. 333-251645) previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and declared effective by the SEC on December 29, 2020. The offering of the shares of common stock and prefunded warrants is made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained, when available, on the SEC&#8217;s website at http&#58;&#47;&#47;www.sec.gov or by contacting H.C. Wainwright &#38; Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 865-5711 or e-mail at placements&#64;hcwco.com.</font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The warrants described above are being issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:6.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About JanOne Inc. </font></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JanOne is a unique Nasdaq-listed company offering innovative, actionable solutions that it believes can help end the opioid crisis. JanOne is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation&#8217;s history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids. Please visit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.janone.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for additional information. </font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-right:174.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:217%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to closing of the offerings and satisfaction of closing conditions, the expected gross proceeds from the offerings and statements regarding the anticipated use of proceeds from the offerings, as well as statements relating to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">statements that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commencement of further clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and other statements, including words such as &#8220;continue&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;hope&#8221; &#8220;should&#8221;, &#8220;would&#8221;, &#8220;may&#8221;, &#8220;potential&#8221; and other similar expressions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Such statements reflect JanOne&#8217;s current view with respect to future events, are subject to risks and uncertainties, including market and other conditions, and are necessarily based </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:90.72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">upon a number of estimates and assumptions that, while considered reasonable by JanOne, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause JanOne&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company&#8217;s </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). </font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled &#8220;Risk Factors&#8221; in JanOne&#8217;s filings with the SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and JanOne does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. JanOne cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:217%">Media Contact </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IR&#64;janone.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-800-400-2247</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ex992janclosingpressrelease.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic3c0332543c147cfa1e6b226fd94dc7a_1"></div><div style="min-height:90.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-align:right;text-indent:-199.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.2</font></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-indent:-199.15pt"><font><br></font></div><div style="margin-top:6.8pt;padding-left:219.6pt;text-indent:-199.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LAS VEGAS, August 22, 2023 &#47;PRNewswire&#47; -- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JanOne (Nasdaq&#58; JAN (the &#8220;Company&#8221;), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 899,348 shares of the Company&#8217;s common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.8811 per share of common stock (or prefunded warrant) in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase 899,348 shares of common stock at an exercise price of $0.7561 per share. The warrants are exercisable immediately and have a term of exercise equal to five years. </font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.C. Wainwright &#38; Co. acted as the exclusive placement agent for the offering.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">The gross proceeds to the Company from the offerings were approximately $790,000, before deducting the placement agent&#8217;s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offerings for working capital and general corporate purposes.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shares of common stock, prefunded warrants and shares of common stock underlying the prefunded warrants described above (but not the warrants issued in the concurrent private placement or the shares of common stock underlying the warrants) were offered by the Company pursuant to a &#8220;shelf&#8221; registration statement on Form S-3 (File No. 333-251645) previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and declared effective by the SEC on December 29, 2020. The offering of the shares of common stock and prefunded warrants was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained on the SEC&#8217;s website at http&#58;&#47;&#47;www.sec.gov or by contacting H.C. Wainwright &#38; Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 865-5711 or e-mail at placements&#64;hcwco.com.</font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The warrants described above were issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:6.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About JanOne Inc. </font></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JanOne is a unique Nasdaq-listed company offering innovative, actionable solutions that it believes can help end the opioid crisis. JanOne is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation&#8217;s history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids. Please visit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.janone.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for additional information. </font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-right:174.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:217%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to statements regarding the anticipated use of proceeds from the offerings, as well as statements relating to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">statements that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commencement of further clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and other statements, including words such as &#8220;continue&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;hope&#8221; &#8220;should&#8221;, &#8220;would&#8221;, &#8220;may&#8221;, &#8220;potential&#8221; and other similar expressions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Such statements reflect JanOne&#8217;s current view with respect to future events, are subject to risks and uncertainties, including market and other conditions, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by JanOne, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause JanOne&#8217;s actual results, performance or achievements to be materially different from any future results, performance or </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:90.72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">achievements described in this press release. Such factors could include, among others, those detailed in the Company&#8217;s </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). </font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled &#8220;Risk Factors&#8221; in JanOne&#8217;s filings with the SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="background-color:#ffffff;color:#302a26;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and JanOne does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. JanOne cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:217%">Media Contact </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IR&#64;janone.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-800-400-2247</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>jan-20230818.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:58bc4d69-38a0-43b6-b1d7-be31e4cd6e81,g:f85bda19-a3ae-4927-bc65-6331e24f9e17-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:jan="http://www.live-ventures.com/20230818" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.live-ventures.com/20230818">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jan-20230818_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jan-20230818_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.live-ventures.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>jan-20230818_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:58bc4d69-38a0-43b6-b1d7-be31e4cd6e81,g:f85bda19-a3ae-4927-bc65-6331e24f9e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_1f12f373-4327-4817-a22a-101c9ed191f1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5b2d633d-8f32-4b3f-959a-33945cc22e7a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_bda83e3c-6267-48ad-9094-ccdf774526ef_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7a4476fe-fa86-4736-8a43-2c05794586cd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f3149155-46f1-4c61-bc7d-6e465f940db6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5c3320ad-bf5a-44cd-b8a0-14ea7504a0ca_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c77f083f-5521-4f9c-b825-4d0610f4314a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_68ab51af-5ec2-4212-ae28-7a74715a7956_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a0af3efd-0941-4cbc-a6db-c6f320e0bfa6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_7e67bf13-576f-492f-80bb-45c6306e2f4c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f82e7104-70cb-41b7-9d1c-4d7aefa6c961_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_5f2c3453-d12e-4274-a122-74313e3047c3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_83f5840c-a9a0-4d5b-9c35-2d3f76d28a33_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4d6eabff-8084-432e-9f43-e4396f5bdda0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f98d8204-fe69-461d-9c11-d53389f6355c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0a778556-272d-49eb-8ec3-37dba6d95c78_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_32725d76-58ce-41fb-b098-afe7922ddfd4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_419e5560-fd42-46b8-81eb-1d9e4636487a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_55c13a3f-f077-4b9b-8578-2a7e7eccbdd7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d5b58654-4903-4c15-af3e-e02e7167e614_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_57ff8317-7609-4450-bfe8-b302e3fd8dba_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_49c0d3af-24fc-4f9a-8b49-34283760a942_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_13a1465b-af1a-475b-bb4e-b33b1c551232_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1b2c5541-ad6a-412c-ba18-df6519380589_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>jan-20230818_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:58bc4d69-38a0-43b6-b1d7-be31e4cd6e81,g:f85bda19-a3ae-4927-bc65-6331e24f9e17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.live-ventures.com/role/CoverPage" xlink:type="simple" xlink:href="jan-20230818.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.live-ventures.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_50506d23-ab07-4ccc-bdb1-01c3d81b7e0a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_DocumentType_50506d23-ab07-4ccc-bdb1-01c3d81b7e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8ab03175-aec1-4b25-b360-b2e633dc9291" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_AmendmentFlag_8ab03175-aec1-4b25-b360-b2e633dc9291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_719b4c70-1602-451d-b324-5379c78557fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_DocumentPeriodEndDate_719b4c70-1602-451d-b324-5379c78557fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7179f51c-17a2-45d9-b9ac-33a73901d7f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityRegistrantName_7179f51c-17a2-45d9-b9ac-33a73901d7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_924eb8d5-6855-4846-aa93-88354e6424be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityCentralIndexKey_924eb8d5-6855-4846-aa93-88354e6424be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8a517a24-b108-4c3c-8eb0-00888491b844" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8a517a24-b108-4c3c-8eb0-00888491b844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f9e07e1f-48c9-4ac7-ae24-759a0936846b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityFileNumber_f9e07e1f-48c9-4ac7-ae24-759a0936846b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0690bb48-af46-44b0-be7e-22b1da616201" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityTaxIdentificationNumber_0690bb48-af46-44b0-be7e-22b1da616201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_96a7926d-bb49-413c-b76b-5f91b5798c51" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityAddressAddressLine1_96a7926d-bb49-413c-b76b-5f91b5798c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_29ba2594-99ef-4fd0-807f-1602e4597071" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityAddressAddressLine2_29ba2594-99ef-4fd0-807f-1602e4597071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_86ba819d-f9bc-4c5b-a6ab-5fd593614fbd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityAddressCityOrTown_86ba819d-f9bc-4c5b-a6ab-5fd593614fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_df68dddd-9aff-41b0-be08-9215242a3fbd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityAddressStateOrProvince_df68dddd-9aff-41b0-be08-9215242a3fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_97de7e76-5660-4954-a278-c1bda940749e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityAddressPostalZipCode_97de7e76-5660-4954-a278-c1bda940749e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_21e1e328-e249-4f9f-aef9-b5ad83f2454c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_CityAreaCode_21e1e328-e249-4f9f-aef9-b5ad83f2454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bfc3ddb2-f50b-478e-8c18-701ac9dd2897" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_LocalPhoneNumber_bfc3ddb2-f50b-478e-8c18-701ac9dd2897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_547ee361-204d-47cf-989e-eb4d63763dfe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_WrittenCommunications_547ee361-204d-47cf-989e-eb4d63763dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2dcc4337-0b26-438a-8bbe-0a47c2f08647" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_SolicitingMaterial_2dcc4337-0b26-438a-8bbe-0a47c2f08647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_802e4984-6445-4972-8497-983e80b02be6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_PreCommencementTenderOffer_802e4984-6445-4972-8497-983e80b02be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_5af2ea31-7095-4fd6-a492-3adca3b6e12f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_5af2ea31-7095-4fd6-a492-3adca3b6e12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c18b9a86-8709-4532-a116-66411905da1c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_Security12bTitle_c18b9a86-8709-4532-a116-66411905da1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b6b471cc-8edf-455c-9859-d889c7a1432c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_TradingSymbol_b6b471cc-8edf-455c-9859-d889c7a1432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c8e3a00b-0919-4f1e-abba-7b771c632d83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_SecurityExchangeName_c8e3a00b-0919-4f1e-abba-7b771c632d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9997c1b9-040e-43a9-9333-b798c4b26dc6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53f3d774-8f5e-4a8b-9f48-c7814cda39b0" xlink:to="loc_dei_EntityEmergingGrowthCompany_9997c1b9-040e-43a9-9333-b798c4b26dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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ML"*PMA5-%0@AA!!"5' LK)A]1%<J%)3W0MB\%M;U&S:ZMKPA7H45@24":++
M=:V$$$((<8HC885L+%FZS%.A\U)8L;M]8FJ:=4GMB,(:DE;4;=V[=Z^K.1%"
M""&D8^%(6"&K7I=W\E)8%Y3Z9RE 1Q36IM+*F59"""&$Q$K,PKIJ=;F56J1>
M"2N*WINL'TMAC2ZM6!Y ""&$$!(+,0FKS76=:>E9;E\#R=QY"ZS+:;P(:TA:
MR[D1BQ!"""$QT*ZPHG154G**-6'+S)KB^D5H:&BPFF,\"BL"U0,VU]2XFA\A
MA!!"@D]48453@(RL'*O"YH6P5E1661?3>!16F5]J.IL+$$(((20J485UWGS[
MK\F]$-:"PF+K><:KL"**IY=P$Q8AA!!"VJ1-8:VNWB1&^Z >J=O"BA)+8Q.3
MK><9S\**]:R556M<S9,00@@AP:5586UL_%I,3LNT+C)>"&OMEBW6<XQW846,
M3YG$I0&$$$((:956A17U5FT+C%?"NG+5:NLY4EB_"U1J((000@AI282P8I8K
MT4?U2-T65A2QMYTCA?6[&).0).KJ=KB:+R&$$$*"1X2PEB[T5[<GMX45&WYL
MYTAA#0<^#T(((820IC035CF[.FZ"=6GQ4EBG3BNPGB.%-1S8Z(>N8X000@@A
M(9H)JY_6KGHFK'D45MLYMHPY<^>[FC,AA!!"@L4^8?WZZZ^E'-F6%0HKA15=
MQ[[ZZBM7\R:$$$)(<-@GK!LV;)3U,&W+"H65PHHHKZAT-6]"""&$!(=]PCIS
MUASKDD)AI;"&8FI>OJMY$T(((20X2&%M:&@4XR=,LBXI%%8*:RC0?6S7KEVN
MYDX((8208""%%6U8;0L*A97"VC(J*ZM<S9T00@@AP4 *Z\)%BZW+"865PMHR
M2F;.=C5W0@@AA 0#*:Q3<O.LRPF%E<+:,E+3,L7>O7M=S9\00@@) NO7KQ<E
M)26BH*! +%BP0.S8$5^=(3LU-C;*,D*VY83"2F%M&:/')G$=JT6^^>8;L7;M
M6CE IJ:FBA$C1HB//_Y8#!X\6 P9,D0,&S9,?/KIIR(E)45,GSY=5%14!*H<
MV=BQ8V4.3B(Y.9E?HCH0Z]:M$\7%Q8Z#XQ+QBH:&!O'YYY^+RR^_7/SPAS\4
MW__^]T6G3IW$_OOO+PX[[#!Q^^VWBZ*B(NWC;-^^76S>O#EJV+[O.VW?7F==
M3"BL%-:V8F-UM:OYD^_ 0+1PX4(Q=.A0<=]]]XF++KI(#HX8&)W$?OOM)TX]
M]531MV]?\=)++XG,S$Q16ULKZSS[C9_\Y">.\SO[[+,#)>4D.F^]]9;C>P"Q
M8L4*VZ=.X@#<9Q#5]NY'2.R##SZH->/:IT^?F.[][WWO>_OBV&./%5NW;G5T
MG-V[=XN33SZYV<^)):Z\\DK1:>W:==:EA,)*86TKOEBQTM7\XQF()&9'^_7K
M)TXXX02E!W<L ?']Y2]_*08-&B26+%DB\%;'#U!8"875/'/GSA5OO_UVLQ@^
M?+B<)8P665E9MD^]3;9LV=+N^;<6HT>/EC.7*I25E3D>HS#.UBNV-H]56)N&
MCK Z/984UJ7+EEN7$@HKA;6MF#MO@:OYQQN8Z<3K^_[]^XNCCS[:-4EM*SIW
M[BQ^_O.?BX\^^DB^8K()A9506,WSKW_]2^F:0K;\"MX^J>3T@Q_\0.E>@>2>
M=]YY2L=\X($'Y'(NIP1"6-&WW;:44%CM"6ONU'SK.4:+PJ+IKN8?+V!6<]RX
M<5(6L?;):U%M+8XYYACQ[+//B@T;-EBY)A160F$U#X557UA??OEEY7$5XWMN
M;J[C8WHEK)@!/OSPP]6$M:AXAG4IH;#:$U8(H>T<HT5.;IZK^7=T\$U[XL2)
M<DUJ:+&^W^+'/_ZQ'*#KZNH\O3845D)A-0^%54]8,0-YU%%':8VI-]]\L^,<
MO1)6K+/%F*\DK-/R"ZU+"875HK#Z_ M+>D:VTNN-> ?7#&5/KKGF&NM"&FMT
MZ]9-KJGU:H,6A9506,U#8=435LR.ZHZEJ!ZP:=,F1\<-A+!FY^1:EQ(**X65
MPFH.# @OOOBB./#  ZU+J-/ +# V@=74U+A^G2BLA,)J'@JKGK"J7K^F@5WU
MLV<[:[P3"&'-RJ:PVLZ1PMIVI$R:S+J7#L#.TDLOO=2Z>.K&F6>>*>;-F^?J
MM:*P$@JK>2BLX5 1UK_][6]&QM"<G!Q'QZ6P4E@IK)HQ82*%-59&C1JE-!#X
M-?!::_SX\:Y=+PHKH;":A\(:#A5A'3APH)'Q,S\_W]%Q*:P45@HKA=5U4 '@
M^>>?]\WN?Y.! ?_##S]T95D(A9506,U#86T^?CF]5\:,&:,];G;ITD6L6K7*
MT7&OOOIJQ\>AL%)8*:P4UIC9N7.GK+N'-4NVY=*M0/<LB(5I::6P$@JK>2BL
MX5 1UB^__%)[\N'\\\]WO'D5)0^='H?"ZK&PYDR9:CW':)&1Y6P=BE,HK,$%
MLGK++;=8%THOXH ##A C1HPP>OTHK(3":AX*:SA4Z[#>>NNMRF,E)B_>??==
MQ\>DL 9 6#,R<ZSG&"U0Q<%-**S!!-)TQQUW>":,F.5$;4!T*#GWW'/%.>><
M(TX\\43Y9UXM14"+5Y6"V&U!82445O-06,.A*JR+%R\6!Q]\L-(Q,3Y#"IU"
M8:6P4E@IK,;!JYX__O&/KBT#P,_%+OT! P;('N"S9LT2U=75LK#_KEV[1$-#
M@PS,\.+/T&(5._I'CAPIGGCB"=&]>W?7FA1T[=I55%14&+F.%%9"834/A55?
M6,&P8</D1(&3XQUZZ*&BM+14Z7@45@HKA97":A2LXQP\>+!Q(<3/@Z2^]MIK
MXHLOOM"ZYCC']>O7BZ%#A\H26Z9G8'OTZ"'%61<5886,\W[L.%!8S4-A-2.L
M&$>Q# H2&LNQ3COM-#%W[ESE'"FL%%8**X75*&EI:7('J"GY@TSV[-E39&9F
MRFH#IL&@6UQ<+$NF=.[<V=AY#QHT2'L3EHJP7G[YY8:N#/$#%%;S4%C-"&N(
MI4N7RN5?AQQR2,3/Q]NPXXX[3CSWW'.BMK96ZS@45@HKA97":HRJJBIQ_/''
M&Y.^"R^\4 JP%ZU0<8R,C RY]M7$N6/PQCHO'2BLA,)J'@JK66$-@?$_,3%1
MO/KJJ[)6ZYMOOBG7]&_;MLW(SZ>P4E@IK!16(T#X>O?N;43V,$.+ :^^OM[S
M/#"X8OVMT[59K<5--]VD=6]06 F%U3P45G>$U6THK!16"BN%U0C_^]__C&RR
M.N&$$V0'%#<*\<<*/D\T ]!=VH#KD9V=K7P>%%9"834/A97"&@T*JP845@JK
MW]FT:9,XYIACM&45&Z#P6LDO)"<GRU)5NCFIWA\45D)A-0^%E<(:#0JK!A16
M"JO?>?SQQ[5E]8HKKI#EI_S&J%&CM*H(H+K!E"EJ8P2%E5!8S4-AI;!&@\*J
M 865PNIGEBQ9HEQ .A077721J*FIL9U*F[SXXHM:^?7MVU?IN!160F$U#X65
MPAH-"JL&%%8*JY_IUZ^?ELRAY$EY>;GM-**"0ORHK:J:XT$''216KU[M^+@4
M5D)A-0^%E<(:#0JK!A16"JM?00%_G=E5#)8F6YFZ"6H-ME9G,-9XXXTW'!^3
MPDHHK.:AL%)8HT%AU8#"2F'U*T\]]92RP"%>>.$%VRDX N>KFBLV7SFM)TMA
M)116\U!8*:S1H+!J0&&EL/H1U"O%8* J<"C0OWW[=MMI. *;PK"$027? P\\
M4*Q<N=+1\8(HK+@OL/QAUJQ9LNE#2DK*OI@T:9(H+"R4L]5??OFEV+U[M]5S
M#0(45O-06"FLT:"P:D!AI;#Z$70T4955%.6'P 21YY]_WG&^J,=ZRBFGR!:P
M3@B"L%975\OR7Z@4<=EEEXFN7;N* PXXH-WK\:,?_4B<?/+)HE>O7N*99YX1
MDR=/]F65"!TP+FS<N%%N3"PI*1$S9LR0O=3QQ276IA@45O-06"FLT:"P:D!A
MI;#Z#13U[].GC[*P8N!I;&RTG882JU:MBKDV*YH@//'$$W)6<>?.G8Z/Y5=A
M;6AH$!,G3A2WW'*+./300Y7O@Y:!GX6?.6'"!+G1S2WR\O+$W__^=T<!<8SE
M][RBHD*\]]Y[,H^33CI)KGMN*O H<X:&%(<??KB4V?;PD["N6;-&O/WVV]HQ
M=.A0*UWL0E!8S0CKLF7+Q&>??29&CAPIWZ:DIZ?'%!!"%2BL%%8**X75,7CM
MJUI0'[-KJ:FIME/0XMIKKVTU-\C(B2>>*/[\YS^+HJ(B*78Z^$U8]^S9(S[]
M]%-QQAEG&.EJ%NT>@>R]__[[KBP;^,<__N'XG$X__?0VUR#CRQ=FB*^YYAK1
MN7/GF'\FED6TAU^$%7)]P047:'^VD/6$A 2CY^84"FLX=(3UW7??53HFE@2I
M0&&EL%)8*:R.P2M@U0<69"?HU^N33S[9EP\D%7(%2<5,JLF98S\)*W+KWKV[
MMK XC7///5=,FS;-:*M>D\(Z;]X\Y9)G01%6+/LP\=ECIOF___VOL?-21558
M;[SQ1MNGWB84UM:#PNJQL,Y?L% 4%!;[-DH7+G(U?PJK_WCXX8>5'UJOO?::
M[=/7!IN*(#"//OJH+,NE\KH_%OP@K)CAQ+I=/-ATA44U<.R77GK)V#(!$\**
M+R;OO/..K+&KFE<0A!4-/71J$(<",\\??_RQD7/21558?_WK7]L^]3:AL+8>
M%%:/A37>H;#Z#\R2J@Q4V&SE]R8!L8#9/K<DM2FVA16R@K7*;K[^CS5P#G?>
M>:>1ZZXKK!#GQQY[3,ZNZ^3D=V'%.M/KKKM.^[-#:^.//OI(^WQ,06$-!X4U
M$@HK48;"ZB_6KU^O/-N&UXI.:Y'&,S:%%;*J\H!P.W[SF]]H+[O0$5;\KF/Y
MAPF)][.P[MJU2_3NW5L[1TC]X,&#C2[IT*4C"BNJ4*CD1&&-A,)*E*&P^HO,
MS$SEA_6SSSYK^_0#A2UAK:NK\Z6LA@+"J"- .L**F4)3,\Y^%58L [GKKKNT
M\\/,*N303[(*.J*P3ITZ52DG"FLD%%:B#(757PP9,D3Y 8:2)B1V; @K[N5[
M[[U76U;<#,S:H?25*JK"JMN>MV7X45BQW.&^^^XS\AGY;68U!(4U'!362"BL
M1!D*J[]XZ*&'E 8I[!!>MVZ=[=,/%#:$%;NX_;!FM;WHUJV;J*VM5<I155BQ
M',%D#GX35LCJ(X\\HOWYX^]CHYY?QT55844Y.US7U@)C&Y9+V8IQX\8IY80.
M?-A$J@*%M7E06 F%U6=<??752H,4.CUYL5&I(^&UL*Y=NU8<==116K+2-+"#
M'MVLSC[[;"F8^-DF9?C55U]5RE-%6%%W&)L&39T[PD_"BC$,'<=,R:J?UZJK
M"BMFC3$CV5J@<QL:7]@*U6H5^+L07A4HK,V#PDHHK#X#XJDR2$%TB3.\%M8!
M P9HR\HEEUPBRSUAUS(&?C0;0 ,%_#<V\J  /9:&H .8KARC#:S*+*N*L+H1
M;@DKWF:@XY837GCA!2-?)B"]?I95H"JL'3$HK)%06(DR%%;_@%]D5<FX__[[
M;9]^X/!26/%:4&=]YGGGG2>F3)GB:,TBRB:A+J_.<8</'^XXUR )J\JY8K8-
ML^6Q@+$+:TU-S*SB2T@06BY36,-!88V$PDJ4H;#ZAPT;-LA77RJ#%&9>B#.\
M%-:! P<J?:X0E7[]^HGMV[<KYSECQ@QQW'''*1W_AAMN</S[%R1A?>ZYYQS_
MW%B%%5\NT/Y6=ZE#2%9U6Q%[!84U'!362"BL1!D*JW]8M6J57*2O,DB]\<8;
MMD\_<'@EK'A=CQ:H*I_K[W__>R,=J/+S\Y7J^^(+U*9-FQP=RPMAA0A@[2Z6
MPMQTTTVR\@+^NV?/GN*""RZ0RQGP!; ]W!16E.C"\@'=7/OW[Q^(F=40%-;F
M]RF%M3D45J(,A=4_+%NV3+EI@)\ZW00%KX05GZO*+-M99YTE:[:: JUN5>XM
MM,=U@EO">MIIITG!+"HJDFMKVQ)YK/'$=8MEW'!+6,>.'2NZ=.FBG;.I+RQ>
M0F$-!X4U$@HK48;"ZA]TA-4O?<2#A%?".FS8,,?'P6O@G)P<H_EB9[O*6DJG
ML_>FA?6G/_VI2$Y.=D7<W!#6U-14Y=_CII\_ZK4&358!A34<%-9(**Q$&0JK
M?Z"P>HM7POKDDT\J'<?T?8_7RF>>>:;C<WGPP0<='<>4L&)6&G5+W2S79EI8
M,S(R9(DNW=QOO_WV0,HJH+"&@\(:B:JP]NK5B\(:[U!8_8..L'[PP0>V3S]P
M>"6LV-V/U_$77WQQS)OJ_O.?_[B0L1!]^_9UG//UUU_OZ!@FA!5M1U]__777
M.SF9%-:"@@)QV&&':>>.!@JH\!!4**SAH+!&HBJLZ(1&88US**S^H;R\7'EV
M!N6+B#.\KL.*^Q@/+[SJ?^655Z0(8L!O^9H>!=27+U]N,-,P]]QSC^.<?_:S
MGSGZ'30AK'_YRU\\^;TW):RHQ'#DD4=JYWWKK;<&O@$(A34<%-9(**Q$&0JK
M?\"N9@QP*H/44T\]9?OT X>-UJQ-P>PA!N]%BQ;))1W88'/&&6?(AX!.&:MH
MQU/II-:]>W=/A17'PW7Q A/".G_^?.6R84WC5[_ZE6S^$'0HK.&@L$9"827*
M4%C] UX#JC8.^-WO?F?[] .';6%M#=SKV[9M<^55.!YD*F66L#O?27<E'6'%
M4@ LH? *76']XHLOC,@JUN>Y\27%!A36<%!8(Z&P$F4HK/[BU%-/51JD(%)N
MK_?K:/A16-T OS^S9\^6=4M5[BVLO?5JAO6**Z[P]/==1UA1=>&DDT[2EIIK
MK[U6?DGI*%!8PT%AC83"2I2AL/J+'CUZ* U2QQ]_O-&:G?% 1Q16=$."3$%0
M1X\>+7O8XY[2*;/DY1K63S[YQ,6K$XFJL!87%RLW@V@:O_C%+\3FS9L]S=EM
M5(452R*PO"):3)\^7:X!]SJ&#!FBE!.%-1(**U&&PNHO4$)(99#"1AV\GB2Q
M$V1AQ>OCLK(R6?/SS3??% \]])"XZJJKQ(DGGB@..>00[=[U3<,K8<5RA5C:
MJ9I$15@[=^ZL=.^T=B\Y[2(6!%2%%4+B5Z9.G:J44T<75HPW3M>;4UB),A16
M?Z'Z31XQ<N1(VZ<?*/PNK%CB@8UX>7EYLI,9=L[W[MU;;LPZ^."#I3CI2E,L
MX96PHJ6JUZ@(JXG 4H*:FAK/\_4""FLX.KJP8@G;[MV['1V'PDJ4H;#ZBZRL
M+.79L?OOO]_VZ0<*OPDK-C955%3(FKJWW7:;?-UF0Z9:AE?"VK]_?]>N;5O8
M$E;\CD^>/-GS?+V PAH."FLD%%:B#(757^"5J.IZ0[R>V;-GC^T4 H-?A!5U
M-['>M&?/GDJ[^-T.KX052QN\QI:P(E!=8,V:-9[G[#84UG!06".AL&HP<]8<
MD3UEJF]C]MQYKN9/8?4?Z)VN^A L+"RT??I&0!XC1HQP=4TC-JHYO;XFA16M
M-S___'-QSCGG6).F6,(K84U(2#!V;6/%IK B;KSQQL"V8&T+"FLX**R14%@U
MR,C,L9YCM,C.R74U?PJK_\"K4=4'H(W7JFYPQQUWR'S0RO2::ZX1'W[XH5BW
M;IW18ZAT%3,EK"M7KI0SJM@L9U.88@FOA#4WU]VQKC5L"RN6!KSQQAN>Y^TF
M%-9P4%@CH;!J0&&EL/J-<>/&*3\ L4,\Z)LY4.8'>;3,#4LE('E8XPEYU:T[
M>^"!!SJ^OB:$-3T]71QQQ!%61<E)>"6L*,7E-;:%%8$O3D5%19[G[A84UG!0
M6".AL&I 8:6P^HTM6[:(+EVZ*#\ !PT:9#L%+=Y^^^UV<]QOO_UDD?EWWGE'
ME)>7.^K$%,*&L"8E)6G51+417@GKPH4+M:ZM"GX05@26 07]BV8("FLX**R1
M4%@UH+!26/T&9@YOOOEFY8=?UZY= UN,'.UIT0K42;[8J'3EE5>*Q,1$1\?R
M6E@QLZJR#$$EL-3@L,,.DR6PKKON.O'XXX^+]]Y[3UXGIS^+PNI-W'OOO1UB
MK*.PAH/"&DF'%M:L; JKFU!8_0DVX^@\_)Y^^FG;*2B!U_VJ9;T@2D[P4EBK
MJJJ,%)MO&9BM/>644\355U\MFP<,'CQ8I*2DB$6+%HF-&S>*QL;&9N=QSSWW
M.#X&A=6;P'W_Z:>?>GX-3$-A#8<-857=J$IA-1!YTPJ4+GZL4%@IK'ZDMK96
M''744<H//Q26GS?/W0H3IJFNKE:6.BP1F#MWKJ/C>26L6*YPYYUW:@L-!OD^
M??J(@0,'BC%CQH@Y<^;(:[9KUZZ8U_-26)OC)V$-?<;+EBWS_#J8A,(:#AO"
MJMH]C<)J1%C=+=-#8:6P^I4__>E/6@^_RRZ[3+YB#P+XC <,&*"<*[HD-30T
M.#JF5\**_N<0:M7<SCOO/#%JU"C'+1!;X^Z[[W9\? IK[''ZZ:>+BR^^.&Y^
M;UN#PAH.'6']][__K71,"BN%E<)*8?6<Q8L7*TE5TX#T!N'ZX37V_OOOKYRG
M2FD@+X05,Y^A$EU. Y(+H7+Z0(@&UK,Z/0\*:^P/;W0J6[Y\N=(#N6F@#:]N
M%0Q;4%C#H2.L+[[XHM(Q*:P45@HKA=5S=&0G%) >;+;Q,ZA)>LPQQRCGB(>"
M2L<@+X052SM4-UKAU;]):<'OT:677NKX/"BL[<?))Y\LRLK*]OU<K$75J;&+
MC823)DWR_'J8@,+:?&RBL#:'PJH!A97"ZF?FSY^O/<N*AQ_**?D1K,$\__SS
MM?+#9B,5O!!6S!RKY(2274Z7.+0'.BJIK(NFL$:/8X\]-N+<L6X9N_YU?BXZ
ML06Q=2N%-1P4UDBTA#4],]NZE%!8*:P4UK9YX($'M!^JD#-4'O 36[=N%5==
M=9567IT[=Y9+)U3P0EB?>NHII;S&CQ^OE%,T4*]6Y5PHK&T'O@!@\UMK0!R<
MEFAK&5C"H5)CV"84UG!06"/1$M9)J>G6I83"2F&EL+;-VK5K94U-G0<? G+W
MSW_^T_C,G0J5E97:FU,0#S[XH/(Y>"&LO7OW=GP,M*-UHX[N\.'#E:XQA;5M
M&9DQ8T;4GY^?GZ_5! 01M-:M%-;F]PB%M3D45@THK!36(/#^^^]K/?2:QBVW
MW");F]IBVK1I<LV?;AYHWPKQ5<4+8561<G0]VK-GCW)>;7'333<I76<*:V3@
M"R3NXUAXY957M.YS""\J300%"FLX**R14%@UR,BBL-K.D<+:/I@5[=FSI]:#
MKVD<=]QQLE22E[.M&*BPD4AWQBD4K[_^NM;Y>"&L*.KO]!AGG7667&]J$FQL
M4VT)2V%M'JAFD9R<'/,Q\%GVZ-%#ZU['/1&4[G44UG!06".AL&HP-2_?>H[1
M(BT]R]7\*:S!8<6*%>+((X_4>O U#>QBQAI2#,9N7F-T6\(#_IQSSC%V[I=<
M<HEVK4HOA%5E#2,^XVW;MFGEUI+[[[]?^5I36)O'00<=))?I.&'UZM7BB"..
MT+KG^_7K%XCUK"^]]))2?A36YE!8(^\/"FM>@?4<H\6DR>FNYD]A#1;8[8^U
MJ#H/OI:!TE>0DI$C1QHM6(Z!:<2($?*UN$Z)GY9AJHN7%\*J4D8*45Q<K)U?
MB/3T=%DI0O5Z4UB;AXJP@M&C1RNW'4;@=R@(K5N?>>89I?PHK,VAL$;>'Q16
M"JOU'"FLL8.ZG)C!T'GPM3? WG777>*SSSZ3N\K1]C-6L.X2#_*$A 19TD>W
M>'IK ;G^\,,/C5Q++X3UMMMN4\KSM[_]K9$:K)! E%W2N>84UN:A*JRXAOW[
M]]?Z+/ [I5H5PRLHK,W'4PIK<RBL&E!8*:Q! ^M.[[OO/JT'7RP!.>S6K9NX
MX88;Q".//")>??55\<$''\A9'@3$<="@0;*;UHTWWBC;4NITJXHE\, W=3]X
M(:RJ\H;9--1PU:&HJ$C6\M2]YA36YJ$JK "-),X]]URMSP.S]CMW[C1\)<Q!
M80T'A342"JL&%%8*:Q#!S&>?/GVT921(T:M7+Z,/:B^$M;"P4#E?[$2?/'FR
MX[Q0W_:%%UY0[K#5,BBLS4-'6$%)28G\&3J?R5__^E>#5\$L%-9P4%@CH;!J
M0&&EL 85K#>]^>:;C4B)W^.RRRZ3LU,F\4)8L4P"%1E4\\;.?G3R6K9L6=3C
M8&,;"MA#%DS,JC8-"FOST!56@-JJ.I\)UK&K?)GQ @IK."BLD5!8-:"P4EB#
M#&8<[[[[;M?6M/HA(*NJ@WXTO!!6\.RSSVI? RRUN.BBB\0?_O '\?+++\O
M PW_&S//Z+B$)1QN7'\*:_,P(:S8[7_MM==J?2[X(J1['FY 80T'A342"JL&
M%%8*:]#!FE9(D=OK1VT$6E-NV;+%E>OFE;!6557)!Y?M:ZD:^,) 80V'"6$%
M:]:L$5V[=M7Z;+!VW(TF$SI06,-!88V$PJH!A97"VA' CG*4S3G\\,,]D1BW
M YN.'G[X8:-EMEKBE; "U=J4I@-M7YVV^47G+2?U/RFLL3-AP@2M+YIXLX+E
M!28J2IB"PAH."FLD6L(Z.2W3NI106"FL%%8S+%FR1&G@\5.@SBJJ$;A=)-U+
M8=V^?;OHWKV[U>N*+P&XKNB:Y.3OH?D!A34<)H458QNJ;.A\KKB/_=2ZE<(:
M#@IK)%K"FI6=:UU***P45@JK.5!! &U+(7XZ#T(;@9(]"Q8L\.0Z>2FL /4S
M378J<QI//OFD_%URVLP Y^RDA2^%U1GH:G;AA1=J?;8H*8<O17Z PAH."FLD
M6L*:Z_/6I!36^!;6](QL7[WN"A+H'X_"]4%8VXK7U.A![N5Z/*^%%4R;-LWS
M+Q)X;8RVGJ@D *ZXX@I'?Q_WCY//A<+J''1NT[TOL/G2#V,EA34<%-9(M(2U
M>'J)=2FAL-H3UIFSYEC/,5KDY.:YFG\\@ +RV)QANJ6KB<##?\"  7(#BM?8
M$%: ST.W^U2L@<\<&_)"L@KZ]NWK^.<X>>@^_?332N<:S\(*WG__?>W6K<.'
M#S=^7DZAL(:#PAI)75V=TM@KA77^@E+K4D)AM2>LL^?,LYYCM)@^8Z:K^<<+
M>!6,_O1HNWK((8<H/Q1-Q1%''"$>>^RQ=NN+NHDM804K5JP0/7OV=+4<&<H>
M)24E1<RZX0N"TY\U:]:LF'-[XHDGE,XWWH45ZX15ODRT_+TJ*RLS?FY.H+"&
M@\(:"1J;J-X?G5:L7&5=2BBL%-:V8N$BNX-O1P/R4EE9*88,&2(NN>02UVIW
MMA8X%@;%H4.'BHT;-]J^%%:%%6"@QZR:3F.!U@+-!E"?==VZ=:T>%^N;G?[,
MA(2$F/.BL*H#N3GAA!.T/G_<HWCM:@L*:S@HK)%H"6MU]2;K4D)AI;"V%965
M5:[F'\_@-?'RY<O%.^^\(WKW[NU*K5"44<)R!!P#:VK=WOGO!)P3ULTZ"90.
M,PWJS+[UUEMR\->YUE@'_/CCCXNE2Y=&7<L(,814.(G\_/R8\TE-377\\Q%N
M-(=HC_'CQXO^_?L[BD<??=2UVL @+R_/\3FU#">?EVD^^^PS*1=. U^D_ K6
M&%]YY96.X_KKKQ<U-35*QQPV;)C2,2&$*N#-"_[^!1=<(,X\\\R8 G6RG>X[
MP)* 6']^T\ ;N4XXV.@QB=;%A,)*86TMMFWSQ\[7>  "BQWZ&"BQH_R&&VZ0
M-3BQ0!ZS2EVZ=)%K(K$))Q3X,_P[_'^P4QD#-*3IXX\_EH-\T[63)#J03+QZ
M'SAPH%PN</311\M9X):SX%BKB.N.:XY9<GQ6:6EICF<Z""$D2'3"VC8_UV*E
ML,:OL(Z?,(G"XP-0TJBZNEJ4EY?+V;G2TE(9^&?\&?Z=W[KM= 1P[V,S&L2_
MH*!@7\R>/5NL7KU:MN4EA)!XH1/^HV3F;.MR0F&EL'K]V1-"""$D&$AAQ3I!
MVW)"8:6PMHRERY:[FCLAA!!"@H$45G3&&9N8;%U0**P4UE",&I,HMF[;YFKN
MA!!"" D&G4+_D#O5GQVO**SQ*:QIZ5F^Z-I"""&$$/OL$];5Y176)87"2F$-
M1=GBI:[F30@AA)#@L$]8L<LW*3G%NJA06"FL8Q+&B1WU]:[F30@AA)#@T*GI
M__"CO%!8XT]8\PN*7,V9$$(((<&BF;"B2/OHL4G6A87"&K_".G)T@JA6;"U'
M""&$D(Y)IY9_4%0\P[JT4%C#D9D]Q=7\_2:LV3E37<V7$$(((<$C0EC1YW64
MCUJUNBVL>?F%UG.,%@6%Q:[F[R=AQ>SJQHW5KN9+""&$D. 1(:Q@UNRYUN7%
M*V$MGE%B/<=HL:!TD:OY^TE8L7:5I:P((800TI)6A777KMV^J1@0[\):5;7&
MU?S](JQH7+%]>YVKN1)"""$DF+0JK&#5ZG+K$A/OPHI7Y.A"YB9^$=;%2UAW
ME1!"""&MTZ:PXM4L7M':%IEX%M:,S!S77Y'[05BS<G+%UU]_[6J>A!!"" DN
M;0HKV+ESEQB?DDIAM11E94M<S1W8%M;$<1-D.35"""&$D+:(*JQ@P\9JJ[59
MXU58QR0DB;JZ':[F#FP**Y8\5+J\1I<00@@AP:==807+OUA!8?4XW"YG%<*F
ML+I= 8$00@@A'8.8A!7,FU]*8?4H1H])%)LWU[B:=PA;PCI]QDR6L"*$$$)(
M3,0LK'OW[A4S9\VAL'H0Q=-+7,VY*3:$%9OY&ANYR8H00@@AL1&SL )(J]=-
M!>)-6)/&31#U]?6NYMP4KX7U.UEM]"P_0@@AA 0?1\(*(*USYRV0&V8HK.8#
M]6^]Q$MAQ3( RBHAA!!"G.)86$-@(Y87TAI/PCJC9):KN;:&%\**^Z1TX2*N
M626$$$*($LK""M9OV"B2)TRDL!J(G-P\*\7SW196U%FMK*SR/"]"""&$=!RT
MA!74U^_\5BH+7)MMC0=AS<C*$;MW[W8US[9P4UBS<W+9%( 00@@AVF@+*\"Z
MUB]6K)0;ABBLS@(SJ[9D%;@AK&,3QXG%2Y:QW2HAA!!"C&!$6$.@E2LVUHP:
MDTAAC2&FE]C?A&126#'+CBH V[?76<V)$$(((1T+H\(:HG;+%BDN)L2U(PIK
M8M)XSZL!M(4)886H8J9X8W6U[70((800T@%Q15A#U-36RAG7L8G)%-91WW6P
M*BJ>(=?]^@4=81V3,$Y^,:FNWF0[#4(((81T8%P5UA [=^X42Y<M%YG94\3H
ML4EQ)ZS(N:"P6&RN\:;=JA.<"BMFS=,RLD39XB5BQXX=MD^?$$(((7& )\(:
M G4XZ^KJ9 W7:05%8MSX]DMB!558\9H\+3U++%RTV-=K.F,1UJ3D%#$U+U\L
M6;I,;-VZ36ZR(X000@CQ"D^%M27H)P^9JZBL$J4+R^3K\JR<7#$Q-4U6'$A(
M&N^IL&)M*>J&.HWQ*9.DG.;E%\HN8!45E6)'?7T@"N5#6+%D WFD3$H36=FY
MHK!HNEA0NE"4?YO'EJU;K6\,(X000DA\8U58"2&$$$((:8__ W(F'GZ,\X.<
,     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139970514378272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 18,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JANONE INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000862861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1454591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">325 E. Warm Springs Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las Vegas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">997-5968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JAN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>jan-20230818_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jan-20230818.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2023-08-18</startDate>
            <endDate>2023-08-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0000862861</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-08-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">JANONE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-19621</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">41-1454591</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">325 E. Warm Springs Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 102</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">89119</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">702</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">997-5968</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">JAN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M)(075T4QD%58!   'A$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF&%OZC84AO^*E5U-F]22. 4*'2!12C=V>RDKK)4V[8-)#%A-XLQVH/WW]SC0
MA'7A!#Y G.2\>7Q\_-JAMY/J56\X-^0MCA+==S;&I#>NJX,-CYENR)0G<&4E
M5<P,--7:U:GB+,R#XLCU/:_MQDPDSJ"7GYNI04]F)A()GRFBLSAFZOV61W+7
M=ZCS<>))K#?&GG 'O92M^9R;/].9@I9;J(0BYHD6,B&*K_K.D-[<^BT;D-_Q
M+/A.'QT3VY6EE*^V,0G[CF>)>,0#8R48_&SYB$>150*.?P^B3O%,&WA\_*%^
MGW<>.K-DFH]D]")"L^D['8>$?,6RR#S)W6_\T*$<,)"1SK_);G]OL^F0(--&
MQH=@((A%LO]E;X=$' ?0$P'^(<#/N?</RBGOF&&#GI([HNS=H&8/\J[FT0 G
M$CLJ<Z/@JH X,QC)+5=D!@/0<PWHV;-N<(B]W<?Z)V*'V;I!:.>"^)Y_]=]P
M%S *%K]@\7.]*Y3E[^%2&P6C]4\5T5ZA6:U@2_A&IRS@?0=J5'.UY<[@QQ]H
MV_L%X;LJ^*XP]<&=##(H2$,6[VEENO#PSN57!*)90#11E2$0A#G%?<36511X
M_(I%FB,<K8*C=5XR9EP)&9)Q$A*HP,J\X$I%&=754;M :Z."X\0(\TZ>^%K8
M2@+&*8LKP7"=WX?3Q^F83*:C!D)U75!=GT,U@IPI%I%)$O(W\I6_5W'A2AY\
M.FV_TZ8(5J? ZIR#-4D"J5*IF/7*"S(W,)1$*C*2&? "M@PK,XB+3Y\1PFY!
MV#V'\%Y$G$RS>,E5%0BN 1F[I-VVCV6,>J5G>N<0+=@;F80PGF(E@CQQ"%^-
M9)->TF:KV>JBA$>N3L\A'(8AV*"^^#@@#W ?>4RJS1Z7O/);9-P@+TS%9)XJ
MD:PU>9(LQ'A+YZ>H<>.\BYVLY,4EYYF $J:>CP&6UD]Q\_X,.+(MF!\+N4LJ
MX7"Y!Z;),U\SC<&52P+%/?TS7#%[9TIN11)4#S>NB4Y=6JX2%#?WSV@SJ0VX
MWU\B/6DI-8J=+J5=C*U<)BCN[_D8#F$O>QH%%[C&BZM<&2ANZ \R@)S,-C+!
M'*Y&I-N]OFQUVQV,J%P4*&[<+TH8PQ-(3!QGR<'=="45+E2WW:#E*D!Q"Y_+
M2 3"@.^0;U#>2K"HD@=7J>/QRT7 QQU[IOAE .GA,+_VNT+8F,'^]7&UJAZ_
M&KU:LM+\?=RI_T<VT3H#LEI 7+86\&B?CUOS0AA8R^6*4/^GY<]DSH,,ZJUR
M)U2C9.L3EMVYD<'K!?GB-3R/DI0ILF51QDD*W=4;IE#L<@WP<=->*!;:\IN_
MQTM967PU K"AQ$!*O_=Q;_Y(&!F_!1N6K/G)#6Z-T'0XOQO^@3&51N^?9?3C
MF*NU3=*OH& VUD!2EE0/+2YXLMS<H[==^\_!-V:?J$G$5R#D-:Y!5^U?QO<-
M(]/\!7@I#;Q.YX<;SF JV!O@^DI*\]&P[]3%7R*#[U!+ P04    "  DA!=7
MGZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKB
MD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;
M=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>
MW&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4
MD*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90S
MP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF
M8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,)
M;2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:
M\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9
ML^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ
M%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E
M\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%
M$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-
MLPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O
M-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=
M##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+
M P04    "  DA!=7EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P
M#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TX
MI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606
MIW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E
M_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU
M@LD/['X 4$L#!!0    ( "2$%U<9117U-P$  "<"   /    >&PO=V]R:V)O
M;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ
M&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%A
ML&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W
M!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6
MC>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<
M_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= 9.MO8(72A]95,. 46=W=3%
M<]0!;\K!XVBLA H#E&^J%977DHHM)]W1ZTSO'R:/6D;KW$JY]_!*MAQSCG^T
M_ %02P,$%     @ )(075R0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW
M+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB
M688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:
MY$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?
M#'!X=/X!4$L#!!0    ( "2$%U=ED'F2&0$  ,\#   3    6T-O;G1E;G1?
M5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS
M3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV
M(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U
M2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z
M6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1
M.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_
M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ )(075P=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    "  DA!=7' O.F.T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    "  DA!=7F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "2$
M%U=%,9!56 0  !X1   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    "  DA!=7GZ ;\+$"  #B#   #0
M        @ &:#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "2$%U>7BKL<
MP    !,"   +              "  78/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( "2$%U<9117U-P$  "<"   /              "  5\0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    "  DA!=7)!Z;HJT   #X 0  &@
M    @ '#$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M"  DA!=799!YDAD!  #/ P  $P              @ &H$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #R$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="jan-20230818.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.live-ventures.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="jan-20230818.htm">jan-20230818.htm</File>
    <File>ex1099janspafinal2.htm</File>
    <File>ex43janprefundedwarrantfin.htm</File>
    <File>ex44jancommonwarrantfinal.htm</File>
    <File>ex45janplacementagentwarra.htm</File>
    <File>ex51janoneopinionforwainwr.htm</File>
    <File>ex991janpricingpressreleas.htm</File>
    <File>ex992janclosingpressrelease.htm</File>
    <File>jan-20230818.xsd</File>
    <File>jan-20230818_lab.xml</File>
    <File>jan-20230818_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "jan-20230818.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "jan-20230818.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jan-20230818_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jan-20230818_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "jan-20230818.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "jan",
   "nsuri": "http://www.live-ventures.com/20230818",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jan-20230818.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.live-ventures.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jan-20230818.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.live-ventures.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001628280-23-030392-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-030392-xbrl.zip
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M$%4@RKY1P=\/]@\.#H-@B<8FIIV).F0,Y3B+*G*!.DE2:0XBAQ4T,A&=KQ;
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MO707C"!1<!/TT<P&1JW^B5U'T#S,!(P0[3.";D813S_'7^O\2)R<]+2U.5_
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M-[1QGPYR-.[]GH/D6JJHJ>$EM? K>S(3#7=.US-A#0L,H%+C'NJ<YJX.;5,
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M</SEGN(+JNIG<[K1G\V(#N=PGW<B"C)UC<VCEVDNFI;F;*=@0X$.;-W)ND]
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MR;WJA6Z0D]S,##E=($VZP06!G*!9-7E=-J*'Z^BDDSN&C>7)C,,<'TS KW4
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MK*DP .#4:-(CH7UR2:DDZ=)$+3G1W*WBI/("\Y@R?NGU6;@#?B.LU>%X'Y5
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M-ER:*;PC6SES@4<RA6SPT%0QOHI6OM])VMC1- ;?_G"UK?&T!)/6B^NTK3=
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M2<&SU+>-.A35*^>[MBRC69 5*-(W=&!G31?S1SS9.\B;;#SR9K-+XLRCL3=
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M\B,X(?=O,:1#"]3(1*^+=Q>%5K+(B.WE8F)O(UM)2JQ^I )2=_K(7<Q.P%$
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MFI'36[V*9@J1+;A8V7:79T,0=Y";'NMY$A8U:@1<P&W9NIX5XTW2N4N7%,R
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MO_BF%+=YY=1(KNE&-,.P%XB8F#2^9_^Q9RH7Y5P]R' N!-0>_BQB<.";HC:
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M7;WVQ>I/M?WZ2D^/'D[X<4=,Q615D$)C6YE+GS0,L6OU^G*.^LLE?<Q20H3
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M!]^2[" M-;O K#^K/,FKJ'2((+_VQB"3X')L&%G(U55Y&@R 8[Z*8B^'X?8
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MMD6*WG+<6\Y!=4H]DN@L?$DM*JFII>U1Z;?&]+W S?96N*,$LC*+)GH4=-B
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MFY6S\ @=&2_]#'=NCW4J' QKIRC*W.TQ(; >O"UYLR#-Q_E,V__67::EDN0
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M9\5<3XJJ^.[R5X1.@>N6R"=R4A"<BLIRBM;?>&"+G23S3I.%:#QRQ>R_*=0
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MT9$=E5VS]WDTHP)@O3$;K3#<J'2#3I4/0(0!R$+:D7WB&&XC4EV+3G,(&ES
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M8CI4;]?IH\80.J>Q4J\NC4;L3/B,\C3-KW4"N6.8W)$*CY<VB>"IW*+*D$N
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M3R>5-%>* Y5?*?K2UEQ:>EK[W8XJ\]8'C<Q'<#7[8;&+97RD8. +M9UC5/"
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MZE.:EHJG)7*G9>),B]OHIS E;5X8%Q471B@*,L/6Y!Y[#; ))2=OO9XQ-GH
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M5\85+F5UY7M!!1?/O0J^!I\ :\>7X-T1:!2Z+Q_=@55L58B]6%1<#9[;:9'
MG[!XCTE3;V][TZW)EK>!;_Q77GSRCI**%V. =X@BWWE&BOS9'5B$2]BIL,OP
MQ_V9_^&L\K*\PCU=Q+2]?5P#.$ME6"3#F,0:+M)T5H17 6R=49%/O'\&V;LL
M]DZS< O."8SJ.H@".%+%5#[\#JS'43Z9POGNPS*@/,-I;^@+KR3[VML(2EN^
M!1%:&Q0%Q'6CC_*]WL^XZS3T8>(]$-^P#R:P82^J//R$L0*81;W902B%,5Z4
MPVZGM:C?X='WP=R#>E+?!Q>FJ0>')_[W#*2N*"0M?-_C0^'8E%X4CV!HD9?
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M83!,6[<F[.J;!,\,G--RA%-2>&%07L%LXE3O/'T!LW(5@T<9%<%-A@<M\#[
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M$ '[7$:ZVUU&.O#A/0,6-#CA[RZ/_N<EC@[_\GLS?&3/[#58F!-4F;A#\$O
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M9J#3"C 4HT7(.WR 70OO]G/'Z?GK3_M/7Q!=K?7>;BN>1$+I2M/3+$&;PX#
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M9EO_5 0)%@WF%$1& JXX(L)[E>JI-#R0@BU:Q+"9/DT*?8ZT%6W4;5YPJ:_
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M ,*F@W(&JRSWE%O>O[MA,;LK;D%(12SN2UQ'&/P!G?1!L%!%L%1IK8,%P)J
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M6@9$N9H6:C$+3M<*R^]C#^""G1CG98K&QT#([QOF1P'(/:.&[O(M,OHIV,!
M:LEUK*,*M56A(LDV4P5>4;$\(]X!;4SE(X+I?)Q*"5^Y/?L5)W"A)O.8#5OC
MBV6 ]M\W,FL?<=)=H,4X\3 AN< U9& 4294$.OTYJM,%23T.SWS66(%(Q4"<
MM\3!&2%+1T029W]B/<\:+;?VZAS4*LA->2^F'##(D]]F)AI%L1W^=[A6A<?V
MY/I5(KF!TZ9%CN)>3RVZP1OZA+&LC-+8Z*A/:DJ!2PY64MO G_B]?/F4_GE*
M_SRE?[Z*],_9EZ=_]EZ\=Q=PSA7''@HT]\N2\]I<9N5K5[@,PY5UYM4GA\$V
MW8#?CE7JI]:=K@9;."G KD)7(])4J\(>"E[6>$F ^MS+.,#JT.X"!P4C*:JP
M$WPH@Q6C\J'S5;X\K[/W2.RNJ>0X/A>;3 !T,=9@<)%<#'H+O'>$(!X[6)BJ
M-[!T,$\F#1H(Q%C-@?PY#(+PY4/3V>4!*!697I42 0@FIK:%_<PH+V6.Z-<%
M\>[21V(;B8^ 5C;C<Y0U-PM*O9'?@"B8P>[ARF!:*XP-H?NR9J: ]7HT.#:V
M"D?_)((:)/,%&*=<+<V'A-,QXBE6Q6!$D8]\!\3*XS6EW\96L .NB\18T/B%
M6P;6^@R/-VY,7(0-_!,S\>Q!N9R]QW)W521*O05R266-T=M93@E*#SK@.*2-
M& J"=8*!=K^\2/P16\34$(9U(252^"S\(.E4I A>@-C/="774>'!Q.*4K()9
M8D^YP0-&L1$H]HQMUY@UEN$% 04IIY+SGZS70C%5)'@4:8GD!T)84=<?K[TA
MO$W4=NV][)#Y#\6PKMD^)0LQX^SBC 8B!QSI^#@#_Q#Y7_'>N!8S6P\)2#*+
MB4'Z]M>[O*1O'1/:7,U9\2A";$W)8HZ]$HCCVK:9N1(+[L1L-+HU9ZUF>2-2
MY=7G33'TAZTQ''"W"S(/0!_*Q>=M]PSO53IRM"4*&^.$:W\&R9&GD^!C+_BK
MJGX+@]?EKSU2(^\KO0"UG>C@YU[P ZBA@G\,G>JQD94W23$7-J1H/!(^P&4S
M<$FM&!Z!RL[OJD+VNTY6:Z>ZF:*2K<'V[OI%L9I[0?!#?HMTTNRVI?PQ%EIG
M=[3;YD1@FHY,%&0C5&Q\'H_*,@DY*8[/K<+7&SF6)@Y+(^57;-\1@W(;I+=
M:E;U:0]H#>-@CM0<Q9<S(BR..HL9(J7Y-;4/>7MS!R8SA4K?+'=I-AC$5+Z:
M8/D8X$'-G]E=&S0+@L7$A;K-9) GA@L5A^;N8I\#%E$?.,9*(6>KCAK2R6#=
MY.1U3$:&'YC]1T974/B5)V+.8361"N\7PMUV%<5QC\",=QT:IC))3$ZT84GS
M\-NLJ4OF;[,NV=0@>4.,.,#*O&$*G#A?G=>2M*OR6[QC7F?PX 66#]E<GDG^
M+'+\-D(I4X^Q^TU"DH4?XZVX6.9XC=_;LS8"$I;$XFZ97'#" @$A5G. E.UN
M2="P')+J$RZ6ZZJ+OH=\&J_,^VSV&1,7FNS47X#A2X WA]H:?30FBFWL5V(Z
M^PA23[-<BMMQHS;2S4ATSW7>H/<(#*2S%030_&A*&"N&('.]X(;RF41<ME.7
M1AD Z^7 G<!%EO;A108#3/[E1K:G 2Q9+)A2\49A>J=>"$TC=E"IS\UB#517
M50$+"]$" R[-1!CR??>IW0 %41(N3,\!T$VF)TD%!*NS95+D4M\5D@E!@X-J
M*D+ EB<L/,!*$DJ0>/5^L$@0GO0"T(F& 4"<?@(RH'+]$+R39,Y=<1'0?XH[
MF #U@8'*&SL!,:61:&OIA)>O <Q%#MB>A_#;&&.[,ZU2Z8,HU417*^$U%XY"
M=!ZPS,6):E(Q0!M;+WH"T.<$(),\GC2230]* ^T7! :][NH99YEQ*Z8;ND[E
MFIA'QY&L7&;HFF=L[:$[X'.+2I&C3^5-:*9BD(N<,I K&&:Z%>ZRG8RNW=,6
MFS0*)I_"_4_A_J=P_Z&'^\\/;!04F%C8#XCVJ)1OF;HS"3B*I0K66)$OL9S;
MFD$V!(6NU"WK(K0"4%!B1E5L G-4N2I++76=&*-2!0["R>C*<0V,3_7^:,;>
M-N9$D6.'C\I+?M58>[\?H3Q5&Z5-1C);%_8FR]!,^9FZ">Q9[(/^R5]M GB2
ME&B K\#O"S@V8D\%'_$$Y:%1MR7L',VH]Z]?R2/+XZ9&2$J>]N!",Y[QY^V7
MYSULZ"!3D-=NQ[)KR9$]>*QI5HG("^6^T.!O1L?<2,_F:RD4R;X.OW.XU0)P
M=3IXI))3N(B[)$YD@K87B=G3T=AVN3L[4HF,*./"NZH)=.' IPO_-3:5F?Y-
M5FG0/@O]@&EU=!]K]5XV)(^2LQ-M;!LRRVB)CF_S':D1&V.^W&95@@<7;LS%
M*6>J8%\:3]9]7^61"[-L'I-98IE4TQ)X=Q/*>..[7M5RZN9[>CL^8'GW_6WG
M1.*]#[S5OIQ'__!31%7550/(5#/DE7\1B8=6O<%7]7S.4?7M/>AA-[X.F.9/
M.VG^)K4Q)E%&?M[=GA:"-?/F\!P&*\_9 F*<Y2DVE'HCT28T8^#8]:PUC)G0
M;]Q_8#C>L,[FLY'(.+91JE2OO4!VU<)181<[N=AB%W$39Y'[;_J]S'O:N/..
MISUP1YV,N_5]+?PE7:7$+!+J:Z+D+O[Q@X6=G0O-&5R4<P"#[75G\J5Y/:[6
M*3HYF,"#BEN'+-L,.S&3W4GS8715%"8#8)S(\1]6C*QS0=OXOF;N2468D7%%
MX-7Z\!!J7Z8J2KTPA0'J6&9J-LML)$QLM#ULJ:LMS(:,M_1QK57:VOXM4_0A
M?5YH*T@G$Q'%F&G";_VRC0Q^^I?MC%_JC+?IJD=XZ!;<YOU*3383LT$O8$8=
M4 1>&8QRR''!LVZ9BS$'3,4B<DPZX9[C44B;$[3GB!+X"3F"'H@_O^*H35.0
MP-V16B08UB*)O69M4[LJ\@>(!_A)S#ZL%)M.,9]7V9$UPWX_[/-_GA!]E<_G
M=- $R5%0'U+&\H=^K]\?()GPQ2%>S#[3*+PXOPPO+R[-8R@P6E=NX!3*=X;6
MQ=87BN^+Z6 \M ^]1Y&7&X;0FA,JH.#QJ0#DS KSP6 0PG]V;0#MT2@<G8\Z
M-^TXW SMIU60H*!DU%WK\_;>6)ADQ;Q?(WXQ7[0PH9U;HU]$!]&K\6W-=5I!
M/VS!8PN,%G;V<?D%V!WVK\*+_KFO9X&%X%\W)P,\FV^)<0A<X#O[>&?6#C;6
M)3>_WWZKP%Q408.6?.R GD&31[*_.%RX]:8N:B-_WE-%CL-\K>0]$]<UJ;&2
M:*&26'+?&49?RM+2QP2G*$G&>X$QNH4,7K(2G<4S(]"M0=[3-@S,:>"U3,MZ
M=E0B)?]"F\C%I,9:G'XS2Y.6*W:F/W&@Q6?Y-X/Z86!^R@H\906>L@*'GA6X
M.+"LP/V%.X_W*<,V(;\Q:%Z<$)K*R]:_B]LS\JDYGFO&W;4/]VS=<"KV#7([
M"]]>1=4/!4T66A18>:"GNO0\'%FH4]^^S@8BMP91XU!G%7&[H"T%LX[A:MTR
MMJZ4 ^R:%Y@77A.V-UK+1+@".Y[??X99NJA;HVC\35(\RYXF8=^[8>VJTJNM
MA?^; _9.>X,.4_>.? O>L2W10H?]3J@.VE948K(%#[6$#:3!X()YOG? L[;.
MMX:%VX_46P<*H@IH@,(V/^4]\!I&)\.SP?GIF9SW$!C6X" $!G1^7U"J._ C
ME&"U0]@<9<YN9T)GQ&S9H'N//1V03"TT5/.R.K&/X=/4[9 Y-\&M9,Z'Y:P/
MUW2M\%[U)E>=.?T32G4H@\^KJLNPG6'L:H2/96B&X9MFW"6F6D9SG("9?TN?
M2G>/;Y.:%W-X.6N6BLB32X?ZQHD$)J/B^/\F<K!L+U*D_5+8^H!C'A?=3+2A
M?CPY/+/RA7,NE,/=URR@RS+O+ WHY_K'6D"'I9U29HZ4QU0U&&%XD?SJLR/@
MD4W*?"T]=42B\//@:G1*M$\,C4G]O42#O^Q=X0%C">WBAH?-L]0)K;X4LG&G
MFG2*%4_T;)4P#>3=603=5%%8QC&OTZDK#CYTZ7.Y585WC8MNQ+'7\QU.TWI&
M>/,BBR SFG1+"M$^[9'35*T!ECBGVFD4$'@Z!K@4%6^&9C>4=5KQW$(>Z&WF
M-E"(2B9#2+6W&2I*]QF*,W8R_K3^BQWT3V;[W\!/U]7:B4L^%K@BZ+U7+6)3
M43=XM)V4FK_-_/)2FA/.]0WKZ1%_B!YVT;I30"=;WQM2/J0!J[ !*0P>4-=.
M:'I$33\>)C047G=$8 GTD@9%\N FA+F9#8_)FX6D$),Y?0$,-[/CU:G_RC[N
MV"2Z&RCC?C_3O=WH!"ZDW=,.X@B#M4'PF-4J:C-[]X[)[ZC.,SG=Q1II6U%'
M%2S<0YC[$W3HJ4?1L;<-XCH<>6_F>\Q-F,Q0$ A1X&::?\_#2#+ Y+C@AL3,
M'Q4DY6YYX=?!W8'N Y:$5U]FA]G!S@)*,VT%&U+01\TC,+:YR+\ 3[.PC01>
M;U?((UBHEXPZ%V(YK*^:T;$%&4WXU5@/[_>?%&MS:C=.'QCG\<J-*+;N-SK.
M-*'.+2BHBF1<\U$^F]G9%FXVGOR$RT=X2EX9^I4.2%3VO(>CCNY"UP/>ZGK4
ME74R6MY T17SBN/P;AED)RB9T;RR?I^P"R'X R;A0;^3AM^VHX%2 @]3\]LJ
M321 0DW?1ET[]4VRL*FW79G6EFA9OJ5BROS8J,2X3^W%_4XTR7(WOD *CD-1
M&*&,. AMA3'3FU^18M1;K/F@+ $UAMOE0^'%$D(>>D?F,"M,R_QA@_5]\R$O
M5GZG!L83=#HY\7YMSL&E0UK9)>JF^*<4S5.*YBE%<R IFLM#/Z9C<-^F.##\
MI:?#%O$\3.ZW^IO@0Z:I-.?C:\!),BVH& K JG$2RV)NS[7BAELQ0C8OME&B
MT[X?)3ID0Z.[>>$&SU>V,Y5JO<6&L(%RG]49F6;Z*R'9Y8O<:=%F%#/8#5O+
M-:T8L)?YAWUPC*@QKIJN<Q.K;;6H7>/&@0Y^9+PUX6@&!E#O#74,W%%?TC62
MX_[V5$="<4Q]MW@*AAQG@2W0Q0*G6?.+3<5<!>9R2^ 3UVGC9UY8C$>R(,NX
MBN;F'@A6O)'<9G3N-N>VE.!Z+1F#J]$(N8QFPW !C9S8@ST<5%KC94&24JYQ
M,VM5:089PQ>28/(\X2VK.&0F[N[J^,DS=YU5NU9D;6-$=D17:.:42&0&B_1:
M+-DWP@\-+]9UB#1M6O)E_5"<_P29@Q'(4:<>@:/##OC%,C@SQ#2?@O5+J>#.
ML!E%I#RU8<:_MU24WE?L))F=GF"ZV'\?%V][L6$-/VW(X/>GTQF5:%,B/GC?
M;!-6&%G#0L;R$P_?./;=")L71ZG?Z5)N+Y5O[4GY0I ?,$OZ)V?@Y.62Q^9;
M!6#KR'G0"=5.E"CT@-2!HI/*.QP*RR9NJ+8>T$\EMG9*MQ6%@(P(6-"-(DZB
MFHKAW>.#.-<R:9(?'*R/TX?WO'4G26R9Z.(-BK<G35-41D[WR%9FQI8Y5->?
MJX9I;BZXYO."..C.,](*.OJ5TW9XJ#E0F)0"KUD,#KP8.I5*?2^5WCCK@<YP
M,E:AK9V%%XD/P>3.[D3)8]37#Q;@LS$:=4.VU,4M,VS=<"FA8IXLQ6G+&G9;
MF_H#>\1'YR:IH-2(1*H?4!%W+%"WHS9M"&2$X+>-%MM8RM@;AX8H/FE!9G3Y
MG1\HF^,EU@ZM\IH:)LA.L,/;4178P>0\^\[9[XTJ HST!WC^JQRT)08'-C]X
M@]!EV ]XZ2N@BA"[/.D;).JT+HV.4ID_V(U_GR2;QX'9461KQ]<H-Q-'AB+A
M(1?$E]+\3.Y(AGD"M6(+Q-E5;%R0;-=SDWT.:2XFB2U2=S)L<N5E>5K38/ZD
M_SN'JH6V!QL/"L15V#HIM]E#%I7W...&C]3*4VSX,-I)Q@%M&O;6'4F5-/W<
M3!MGQN \+%V<V*.F\<LV5+7:[]TMDAL4A\)6V)W.^".A0+@-@U_KO))3_ERM
MGB^;/,W?X44\T"T&,%@YIGR9,]9I?AL2\=N)=I2J9P6/PL#(/5X<'4I02@-4
MU7FC=P.8\A*THSP&W\^3\2BQRL5/(%8B( GCM#F8FJZI&8I3:4!>H87H3Q14
MM9S.13ZGF;+H&H[]."OF5? ]( 5YBN@"1RN6C1AL@-8MOB;D::*\:)FL1A+(
M]IE96=PF;+F_1LQ(-,KYE'.3"S+S52M[5A8;MBP+*0]5'K*7\A$XMI!*5<*9
M=TH0*9+:F"N>?^=,'1'; (<)?X(+3596O)7*C2'F/@=.ISY%Q9^BXD]1\8./
MBE]]452<>=H?T#VXNMP[F?@_&", 1R E[5J4X3WAO[F[X>CT45?^"ODT^ &[
M9W_\\=V3A/WJ).QW&*^#OV;5/'WY?U!+ P04    "  DA!=7I4D-K)X-  "^
M,P  '@   &5X.3DQ:F%N<')I8VEN9W!R97-S<F5L96%S+FAT;=U;6W/;-A9^
MWU^!3;JI,T,IDFSYWLQXG&0WG33-V-WM]&D'(B$),4DP "A%_?7[G0-0HF3Y
MDC:I/9N'Q"9!G/MW+D!.I[[(7YY.E<Q>_NWT[YV.>&72NE"E%ZE5TJM,U$Z7
M$_%KIMR5Z'3BJG-3+:R>3+T8] :[XE=CK_1,AO=>^UR];/8Y?1%^/WW!1$Y'
M)EN\/,WT3.CLAR=:#0]&<C!2X[XZW.OW^X>#PP.5[N^-TN'!0!V,_]M_@D^Q
M/'SC_")7/SPI=-F9*J)_?-3K'@PJ?S+7F9\>]WN]?SSAI2]/QZ;TH&?Q??@Q
M;'-],VDGV,^;ZGB_>XBM*IEED+F3J[$_'O2/NOMXZ-5GWY&YGI3'+'AXH,L,
M,AYW^D='W?ZP\D\"V6;KU.3&'C_M\9\3>M,9RT+GB^/O?]&%<N*]FHL+4\CR
M^\3)TG6<LGH<%CK]NX(\(,V_SH.X!]@GUZ5JQ \"O_X\U2/M!7&Q+NT?D_,&
ML;9H\ZON_U>K[4=9_EPJ\8M*IR5(3C2V/BM+4Y<I?KI0$^V\LHB!5]JJU(N?
MQV,00C1\L#K%XS/?^66J.C])>Z6\J"&4%>^ER^0G<5'GRMU'5;UN_Y[Z75/G
ML*5?]L?C8?=PN.ZG'VOG]7CQ0,I]=W8I_O/ZGV>7B3BK)V!%] ^3 !?/GNX=
MG'RX "$WAV;Y5V"':$3_MNSNW>8+.\%^SYX.#T_$CV?OQ8Z?*C!\.!CT3LY-
M4<ERP;_U3YXG0HJ1-M54VD*FJO8ZE;E(PR+A*I5J&.)W<AA=BDS-5&XJ^JTT
M98=LEWKZK9)X>Z7S7%DG9)D)3\A+V.G$V-C@5_F"EJ:R=A#9C/FC1'B3R06^
M"2Z++Z?2"^# 5#J![]EW=>D-&,W46)?:ZYD23J6UQ8_8J:IMBL5*R(E5BG&?
M2)+,JU=@R<E<$=G#HZ-D=^]0.,@<&*&E+;WT#TX<J: P)2QHTBNQ@_TJJ\8D
M1B;FTEI)DD'F7*N:OK?*C)\+<"Y71"N*,-K_NU[W\+#?%Q5BBZG2P[L)/"<"
M4MA5#&<AADT3PU6(8>D[8*%3;(EA2S'<%6^Q$8SEM8'&>=?4E-"@)6UAEQG2
MI*AR> #I+VEK1,QA5J&=JQ6V;C&S5 -LLY3YNG+7Y"0%E4)]5C;5&QHZ&.ZW
M--05 K"THD%*BY_)$>RHBT)E&ESG"S;N5,(II !G!>VWI* ^U?!G<#@FKUDH
M:5W<.LT-5P71_K=HF?V9OKA%95 0B")<J-P .9-BJ8#<,*P<F=HW #(8! !)
MA*M''XD.5M/N3GKMQC(E&['>L!J08!=+3D$_F-!U[X?*>_=->YNP_,WA=CM^
M_:M[WA6_ A7FH2Y[]G07"'9NNJ1=&9 &J$#:4I_3'%7=K&T".6G'?F.^;ZVK
M:RGLZ&$RV#65]@^@4O+TB34.,&E-JE3F&G]KPGML3;&FL";85LX\0FA5^/ZS
M+D+$?7=PU$O >()7T+<",F=UL _#[KI)EI@Z5BID!T.(N0HPHE524JCD@J-[
MM&BSV.5X;?A%+E!E$ .)A->5RJ_$VR(/N<2<RGM./Y7V@ 1B \PIR^G.5L9R
M/-?X"9S<TVD&7\MGA@]4]FR/0U+W=@!/MJ5!3J[;\;Z5]]DQKG^,GBRU>D19
M;&00SCLC8&5I/*]?95I*/U0'W W$,?SOQU!#X#G[_$B%A##F-+#NA.0:KL9:
MP:5(K*;<5.7C6$O%% (_TDP.; 6&2O'&("U==G;%SAL-]WX/1-O=W>T,AOW]
MO>%S4LM,F]HALL9X#^UH/V7BEZLRA[3\^C.R;#EAI@KHA BUB[O+U^=-8<?K
M,Y7FDF11D"GEPBE*A97$V"L%K8T0BX,C3DN]$&O+R(S)\:9L#A+;RB(G"IEA
MEQ("@5ZAX(OTL:0HI9K2UX[*$$!XQIC>>HZT6%5Y+$,0N$5<(*UON%D)LUWC
M77$&/98([*W;,MLRC35N**.6RZS*9< Q<U=9P'41H''39*^1Q%[G6&I-J5-H
MK-*K,O./\E6@1@8M,_)(CRI+Q'RJ4,;-I,X),1,R9J2^A-NY&CF-V$#1-?6^
MXGZ ^Q3^:SZ?=U%%=R=F1C$#.R&L?,RR-V;B1+Q[=TX[[NWVQ <4G.)LILH:
M#.S:3+S)C;$)P]!OP%O\])L I%#-@_VKJ2F9FYU!?_!<'.X/.\,#E,6@3L6K
MSNG=,I#=LZ?[>R?3=)Z:+G1R,R+_27#]OT/N&Z%U!7$K.+V]$8B]Q*4*5>G>
MCGR^ \M%7VZ!TQD'AN@?[:*P18DF\35APAHXK2UO-:!P^PLUJ?,0QJ_([8LZ
MG_#DCENKP 7687%N./1BL'T9RB>A3:#L,E((GU9P!Q+7I4JX@$>(HB^FRH1!
MIMU]YG*.CN(,86O)+_)%LIZY2+H6.S<P3.$=V%JF']!U)E_FO'^C\<732Z)/
MK4:J*K^>D\H[@9%E*=OBH$\J*EZT+)O6/K7HGP![H9'?;G;._G4ZO5M+UX+L
M*P3@/HV>'E/\::JTE>-,HJ@CAL61)\BXB#3PYFN"Y#+8F0SG%-Z39<C>.D5U
MVK2 [56CFA.W:ZLUP;8V$N! X4J=YC9QU+'Y 4<\O6?[X-M0B'_$:\>C'-#%
MDOE4PYYL5*:?;'!F X&YJ>&?(QH+P+[CFO*:-G8]==KE-]2)ZS$\A!^L F[#
M38+@BT#^%D;O6:+O?OGDM]?M/:HIY!G/#^)P[VV9=L77D.)V=3R:B(IBTP
M/J,_U2J.MCHY87>VG%4NZS)=E@9I##"8B#!."9AD\IJ')\L)XTCE6LW :HI
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M REVR1\'W&RF/K!>_<Y1K]?!N\Y@L'_XR*GT=_&_>7S'_[WD?U!+ P04
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M!<O=\[1F1R5%38Q5N#"%U#%YE7ROX*_<EPKP9:(.D2W,Q.4"2+1ET^"Z &Z
ME50>GP''89P@(#@+%CP\,NQKBDPRKRD'& RA4GAQ^I4@[E:53PVOW#E&>4MO
M>P71\\W"]CP\V/HKYE#>O[_0!5.T_VD1]L!"(*O+]%Q9#$.N@7;;,'<21=P9
M:ZO+B"]K56R2L2A8(6.;'7T[J*\ZG_C\]+[]N&(C/:ZXX.R9&R_,@8H51Q0W
M/!"X^@.Y6TH5.J'7J-3J[*.?"[OTN3EN@I5&T3Q'JIW2R"1HN(/GC3<E*%A.
M!C[+3BCR 5B?:7FB$;:5&[J1K-7)A*S'AC$H[:%DNZ#>^(J;(9V%HSTU7:\'
M2^WAX2[Q9R*U[51J]9=T3O!3C ^6T79CEVA :]Y&'LWCOGN"N.J<;-Y7-(%8
MC'GAB7$018%F,/?](/:=M+(XE,ZJ(L0[(VJ;#;^NQI%E^S5=X)7$@/)CD3 /
M8W!7U=A(,D8RLTVWTX%=5P<6TP< *XPQU<'")$WBFTR&-N &6%T-*H34TB#-
M,9!MGF12,4:5U#PC<.GI_/;&U[P\?_H"V.2V]$4>[.>#,'\"+LP=]$AB$XF=
M)OE >L: '^K0F!(F3)09YV:A%Y=XO6-D+'43PEI?>;5\I^>7:XQ5GOSF6K=3
MVR6MFPA0)]UYWJ6WO_2S>&E.FA^\'756;LEX!Y@%U,!07)>.X(3S5]M*+=JC
M.KA'W4FE93:\G;GR]Y[@N00_PGM+6ZW'OZAH0USQ"]CKD;D;W@<CNJ;CU[Z?
M!S:M1J?QD.MY[$:ET=[L!M?[#-MN5IIVYSF_.?>U=R&ZULS8$&<Y#_[1+K)^
M5LS>9E'6)[\+=>N0;U8:SW6?YEJ$A\,G0_@V>^\U7[D7"LWXKYX=0#8.\=X^
M<=-L_,5]< 7T47N3>AI*OS*.@+3ODLC_4J*@3&DH=T7E+5_,EWQCR@LT]A,J
MK1=>_@)>;@(OZSL\,D;F7I&57_BWTGKAW^WDWQ;JXB3F2G7]Q,<+NGA=%O9[
M9>A6Q7YAZ*UDZ)8-#!WXPJ0(AT$XHR,NFJ'/UR4.OP.>I7*#%Z[=2JZU:YT.
M\"U0C\R'>E']WGJKXX(23I(%WP%# Y)/J86? Z5>X"MS;&.AL&$O+<R4?KXL
M8;]R'Z=_EVB!Z9\7=;65ZJK3L<F%I]PB)?5T3D^KK8M"QO![U4Z8K'QAWRUE
MWSIZ[3IWG6-?<2?_?D<NCEU[RIC3\VRNUWB7(SBY[!2OS>;ZQ-%;'G%&9Z#V
M\-B1FQQ^2.\@Q)'8GS]?OD_+?U=MNFN_M;,EU>J;)UCM+/.\'27NM+Y/_A6F
MSEWIS/KMZJ]_^LO9\=7'RY/^IM\*69&0?E7(9QX\?M9V$<O5GSM9O)HN%'_'
M,LP./6U0(5-F,Z$/,+NQ-V=T2ZBKR_)"7>BM:S?HK#;=J(%E\@,QYMXP.>I(
MU#4-]%4JT(>&XW$T#D) R+W/YY1VYLLLS4ZEUGJ"U&_EL-E^]%$;[<?^TN@]
MOO'\K!O/G<)$JY_[NL4]=M15'Z]>V%+L^A-^+_OQ/ZW];:WJS_/NKMA'*4(T
M8!?O@97.!BA6595=!?Z<G2K.G8?$&;ZM)<</3VZRZ%M>6K$9LB\+GZ,%?CMW
M]\3]5IS0RY5N<K2]-Y9B"'8<V'3D%)T/A](1X:JE7]R$FCNU">W RKS%B$,W
MB3CH2S,VJ7)Z% INNQM;'03N'/X91Q/OZ/\!4$L#!!0    ( "2$%U>7AX(W
M<P(  (D'   0    :F%N+3(P,C,P.#$X+GAS9,U576^;,!1]SZ_P>)X#A#0%
MU*326E6:E&U5UFI]FPQ<B%=C,]LDZ;^?[8!2^K$VTAZ6EYA[S[D?Q_?"V?FN
M9F@#4E'!YUXX#CP$/!<%Y=7<N[VYPK%WOAB-SCY@?/=IM427(F]KX!I=2" :
M"K2E>HWT&M /(>_IAJ!K1G0I9(WQPM$N1/,@:;76:!),HA[6>V5Z$F?YM)@E
M.(I)@*=1-L-96)SB#*(0IGDQ@SC\6*5E?)(5)$PPB0C@:3(QB'QV@F>1@4VF
M90+AJ0NZ4ZG*UU 39%KC*MVIN;?6NDE]?[O=CK?16,C*GP1!Z-]]67YW4*_#
M,LKO!^A=)EF/CWSKSHB"'OZ+\ &:T0W@C5&GE:#&N:A]VW(0A[&'B-:29JV&
M*Z/-)92D97KNM?QW2Q@M*11&> 96V@'@D5L368'^2FI0#<GAO9D7(X2L*+1N
MA-2(O\CO5 F3)/%WMDT/[45<BIQH-QNOJN+PV!YQ.,%1.-ZIPO/?E788B'*E
M"<_AF-SF"?>\?U'#X8J/JZ'G'5^#"Z8@'U=BXQ= W<V]G%Z]!K<'; _#G(1S
MH1W?6CI;TU!>BKW!F&SA:5_]"LI^:YZMP@LCXOY2(G,IV!OSY#=2-" U!?5X
MC5R M81R[IEEPOW0_F0D&YM">L2S^,,;L&[?4( M#XWT7/W0&*XR^C/82_,?
M]]U(.+9O0U%F\=TU']F^Y=\8/Z+%W+L0YC-P32I3GK7?KCZ_\89QV0^L/G0?
MO("2<NJ&+W"_$.'#YP,CQT26>N8_)3P)U2HHOO&%.S]MMR-WD+\0<\+REAW/
M.Y3U*JTS]G)VR^8/MVW__&@CG6&_YHO1'U!+ P04    "  DA!=79HDZ4K,*
M  !$8@  %    &IA;BTR,#(S,#@Q.%]L86(N>&ULU5U=;]LX%GWOK]!F7W:!
M82U^2)2*MH-NIAT4FVF#)L4,=K$P^)D(M:5 5IKDWR\EVXD42S8IV:K[TCCV
MU>6Y)SKW\I*4^_K7^_G,^Z[R19*E;T[@2__$4ZG(9))>O3GY>OD!1">_OGWQ
MXO7? /CK7U_.O-\R<3M7:>&=YHH52GIW27'M%=?*^S/+OR7?F7<^8X7.\CD
M;ZO+3K.;ASRYNBX\Y".\-EM_FK\*(BZ(#&. (^8#@GD(.)04<(6A(D*&*H*_
M7+W24< E@S%@F"E 8F0L1!B $!LS1'2L(*V<SI+TVZOR'\X6RC/AI8OJUS<G
MUT5Q\VHRN;N[>WG/\]G+++^:(-_'D[7UR<K\?L/^#E?6,([C2?7IH^DB:3,T
M;N'DKS_.+L2UFC.0I(N"I:(<8)&\6E1OGF6"%17K.W%YG1;E;V!M!LJW $0
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ML3HPX234KI![:73#V6CR[ JCKLQ.&W=17N:L7,F]>)CS;#;5&)(8!@$@H8:
MB! "+J@$H2)AH&/B2Q[:*K+A^=CDN +G+='92[%)UVX=]B;AT'-<N_B=!-@:
M:R_U-3V-)KW6 .JZ:S=P%]W[M##SXH^IR/*;+*\*ZT7!"G6:W:9%_G":2=.
M"HR1;Z:T7 <,$"+,JW+[ Q+%:. 3Y@OK!M1BO&,3Z!*RU\#\BU>A-C1[*^1>
M"=U>O3:\[];TGMD\L-+W0:13&G"@IU=RL/$_6LIP"+:>2%PNZYM>WDEI[J-%
MY?=S?IYGWQ,3SE10JOT(:Q $R)1X'0N35Y"I^-(/H:^)F0$XYI7V@8XTH:S
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M58Y&WPBJPV_;_VE\WK?2GAI'.9M]-/WL_;_5PQ0;K062AB"(A ($:@ZX'T>
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M%=QAUR7>.N-&[M_>OEB_DRS_TX&W+_X/4$L#!!0    ( "2$%U??0 -HV 8
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M>#C?%IO+\L]CZQ3SP_F_; 5M;(FFNC7\UR_G+K[X<(G=HY5NS&=XX*&+UM@
M?^)M$ZL0[P>[,U76_DFCLI6Z3KLS2^MBV1U=AE@LNYZ/W;9)UC=+R7,>E!*@
M<XF<6>W Y$*#5YHBC98;1YX.O_5]B\YWD=E&O[^JKQ?8\:+5I/W0B=,)\\S<
MO4"O\WMW*5Y@VZ4DDF2!<;".*!#>>W#!42#4\Z"I4Y'806X_MO;4Z\>!/4Y^
M5J<0$\XE.W,V^6=!?DKQ0XO%I4W8$?AU48;=V7FJ-V/$JJE'4.X^+.CN?(:C
MSF-*,9S=1^6;@^M&UN ,&[N60R)^C$Z'UO$/I5TM-3K,J9)@HZ<@')/@>$;
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M+FAT;5!+ 0(4 Q0    ( "2$%U?/K'Y^<#X  #^T 0 >              "
M 6^H  !E>#0S:F%N<')E9G5N9&5D=V%R<F%N=&9I;BYH=&U02P$"% ,4
M"  DA!=7&J0U/,9%  "YW0$ '0              @ $;YP  97@T-&IA;F-O
M;6UO;G=A<G)A;G1F:6YA;"YH=&U02P$"% ,4    "  DA!=7I^9W&FI%  "*
MV $ '@              @ $<+0$ 97@T-6IA;G!L86-E;65N=&%G96YT=V%R
M<F$N:'1M4$L! A0#%     @ )(075_+M^6M")0  O.P  !X
M ( !PG(! &5X-3%J86YO;F5O<&EN:6]N9F]R=V%I;G=R+FAT;5!+ 0(4 Q0
M   ( "2$%U>E20VLG@T  +XS   >              "  4"8 0!E>#DY,6IA
M;G!R:6-I;F=P<F5S<W)E;&5A<RYH=&U02P$"% ,4    "  DA!=7BAB[@#<-
M  !E,@  'P              @ $:I@$ 97@Y.3)J86YC;&]S:6YG<')E<W-R
M96QE87-E+FAT;5!+ 0(4 Q0    ( "2$%U>]3R8+^1D  'NS   0
M      "  8ZS 0!J86XM,C R,S X,3@N:'1M4$L! A0#%     @ )(075Y>'
M@C=S @  B0<  !               ( !M<T! &IA;BTR,#(S,#@Q."YX<V10
M2P$"% ,4    "  DA!=79HDZ4K,*  !$8@  %               @ %6T $
M:F%N+3(P,C,P.#$X7VQA8BYX;6Q02P$"% ,4    "  DA!=7WT #:-@&   -
M,P  %               @ $[VP$ :F%N+3(P,C,P.#$X7W!R92YX;6Q02P4&
2      L "P , P  1>(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
